| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ROCK2 NUSAP1 MYH7 MYH8 MAP1A CENPE MYH7B KIF21A SPTBN2 TMOD3 TMOD2 MAP10 CCDC88C SETD2 BRCA2 ARHGEF10 RMDN1 TLN1 MACF1 AFDN UTRN KIF11 | 1.36e-06 | 1099 | 126 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH7 MYH8 BRIP1 ZCWPW2 CENPE MYH7B VPS4A KIF21A MCM4 RFC1 SMC2 MDN1 SMARCA1 MACF1 DDX41 KIF11 | 1.64e-06 | 614 | 126 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | tubulin binding | NUSAP1 MAP1A CENPE KIF21A TMOD3 MAP10 CCDC88C SETD2 BRCA2 RMDN1 MACF1 KIF11 | 1.73e-05 | 428 | 126 | 12 | GO:0015631 |
| GeneOntologyMolecularFunction | microtubule binding | NUSAP1 MAP1A CENPE KIF21A TMOD3 MAP10 CCDC88C RMDN1 MACF1 KIF11 | 2.62e-05 | 308 | 126 | 10 | GO:0008017 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.04e-04 | 118 | 126 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH7 MYH8 BRIP1 VPS4A KIF21A MCM4 RFC1 SMC2 MDN1 MACF1 DDX41 | 1.12e-04 | 441 | 126 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | actin binding | MYH7 MYH8 MAP1A MYH7B SPTBN2 TMOD3 TMOD2 TLN1 MACF1 AFDN UTRN | 2.30e-04 | 479 | 126 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | actin filament binding | 6.01e-04 | 227 | 126 | 7 | GO:0051015 | |
| GeneOntologyMolecularFunction | chromatin binding | TICRR VAX1 BRIP1 PARG MSL1 SMC2 JMJD1C NCOR1 KMT5B SMARCA1 SMARCC1 NCOA1 TOP1 | 8.04e-04 | 739 | 126 | 13 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription coregulator activity | CASP8AP2 BCORL1 TRIM31 CIR1 JMJD1C NCOR1 TCERG1 BRD7 SMARCC1 NCOA1 COPS5 | 8.74e-04 | 562 | 126 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | LIM domain binding | 1.38e-03 | 9 | 126 | 2 | GO:0030274 | |
| GeneOntologyMolecularFunction | cadherin binding | 1.41e-03 | 339 | 126 | 8 | GO:0045296 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.41e-03 | 130 | 126 | 5 | GO:0005200 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 1.46e-03 | 599 | 126 | 11 | GO:0050839 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 1.61e-03 | 134 | 126 | 5 | GO:0003697 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.76e-03 | 38 | 126 | 3 | GO:0000146 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 2.94e-03 | 13 | 126 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | vinculin binding | 2.94e-03 | 13 | 126 | 2 | GO:0017166 | |
| GeneOntologyMolecularFunction | helicase activity | 3.30e-03 | 158 | 126 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | histone modifying activity | 3.35e-03 | 229 | 126 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 3.35e-03 | 229 | 126 | 6 | GO:0003714 | |
| GeneOntologyBiologicalProcess | chromosome segregation | NUSAP1 BRIP1 CENPE VPS4A SMC2 MAP10 NCOR1 BRCA2 ARHGEF10 RMDN1 BRD7 SMARCC1 TOP1 TERB2 KIF11 KNL1 | 2.26e-08 | 465 | 125 | 16 | GO:0007059 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | NUSAP1 BRIP1 CENPE VPS4A SMC2 MAP10 BRCA2 ARHGEF10 RMDN1 BRD7 SMARCC1 TERB2 KIF11 KNL1 | 3.51e-08 | 356 | 125 | 14 | GO:0098813 |
| GeneOntologyBiologicalProcess | cell cycle process | ROCK2 NUSAP1 TICRR BRIP1 CENPE VPS4A AHCTF1 TMOD3 MCM4 RRP8 SMC2 MAP10 PRPF40A NCOR1 USP8 SETD2 BRCA2 ARHGEF10 RMDN1 BRD7 SMARCC1 TBX20 PLK4 TOP1 TERB2 KIF11 KNL1 | 1.13e-07 | 1441 | 125 | 27 | GO:0022402 |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | ROCK2 NUSAP1 TICRR BRIP1 CENPE VPS4A AHCTF1 TMOD3 RRP8 SMC2 MAP10 PRPF40A SETD2 BRCA2 BRD7 SMARCC1 TBX20 PLK4 KIF11 KNL1 | 1.74e-07 | 845 | 125 | 20 | GO:0010564 |
| GeneOntologyBiologicalProcess | sister chromatid segregation | NUSAP1 CENPE VPS4A SMC2 MAP10 ARHGEF10 RMDN1 BRD7 SMARCC1 KIF11 KNL1 | 4.28e-07 | 254 | 125 | 11 | GO:0000819 |
| GeneOntologyBiologicalProcess | chromosome organization | NUSAP1 BRIP1 CENPE VPS4A MCM4 RFC1 SMC2 MAP10 BRCA2 ARHGEF10 RMDN1 BRD7 SMARCC1 TOP1 TERB2 KIF11 KNL1 | 8.61e-07 | 686 | 125 | 17 | GO:0051276 |
| GeneOntologyBiologicalProcess | regulation of cell cycle | ROCK2 NUSAP1 TICRR METTL3 BRIP1 CENPE VPS4A AHCTF1 TMOD3 RRP8 SMC2 MAP10 PRPF40A SETD2 BRCA2 PES1 BRD7 SMARCC1 TBX20 COPS5 PLK4 KIF11 KNL1 | 1.72e-06 | 1256 | 125 | 23 | GO:0051726 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | ROCK2 NUSAP1 TICRR CENPE VPS4A TMOD3 MCM4 SMC2 MAP10 USP8 SETD2 BRCA2 ARHGEF10 RMDN1 BRD7 SMARCC1 KIF11 KNL1 | 3.97e-06 | 854 | 125 | 18 | GO:1903047 |
| GeneOntologyBiologicalProcess | cytokinesis | 4.31e-06 | 204 | 125 | 9 | GO:0000910 | |
| GeneOntologyBiologicalProcess | organelle assembly | RPGRIP1 MYH7 TAPT1 CENPE VPS4A SPTBN2 TMOD3 LAMA5 TMOD2 DYNC2I1 MAP10 CEP128 NCOR1 MDN1 ARHGEF10 TEKT1 EIF2A PLK4 KIF11 JHY KNL1 | 4.62e-06 | 1138 | 125 | 21 | GO:0070925 |
| GeneOntologyBiologicalProcess | microtubule-based process | ROCK2 NUSAP1 MAP1A CENPE KIF21A DYNC2I1 MAP10 CEP128 CCDC88C NCOR1 SETD2 CFAP52 BRCA2 ARHGEF10 RMDN1 TEKT1 MACF1 PLK4 KIF11 JHY | 5.63e-06 | 1058 | 125 | 20 | GO:0007017 |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 5.90e-06 | 212 | 125 | 9 | GO:0000070 | |
| GeneOntologyBiologicalProcess | cell division | ROCK2 NUSAP1 BRIP1 CENPE VPS4A AHCTF1 SMC2 MAP10 PRPF40A USP8 SETD2 BRCA2 TOP1 KIF11 KNL1 | 2.13e-05 | 697 | 125 | 15 | GO:0051301 |
| GeneOntologyBiologicalProcess | chromatin organization | METTL3 BCORL1 LAMC1 RRP8 MSL1 JMJD1C NSD3 TASOR2 NCOR1 SETD2 BRCA2 KMT5B BRD7 SMARCA1 SMARCC1 NCOA1 TOP1 | 2.92e-05 | 896 | 125 | 17 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of cytokinesis | 3.11e-05 | 99 | 125 | 6 | GO:0032465 | |
| GeneOntologyBiologicalProcess | muscle contraction | ARHGAP42 ROCK2 MYH7 MYH8 DSP MYH7B TMOD3 TMOD2 TBX20 UTRN RNF207 | 3.26e-05 | 400 | 125 | 11 | GO:0006936 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | METTL3 CENPE BCORL1 LAMC1 RRP8 MSL1 JMJD1C NSD3 TASOR2 NCOR1 SETD2 BRCA2 KMT5B BRD7 SMARCA1 SMARCC1 NCOA1 TOP1 | 3.29e-05 | 999 | 125 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | DNA repair | TICRR BRIP1 PARG MCM4 RFC1 SMC2 SETD2 BRCA2 KMT5B BRD7 SMARCC1 BOD1L1 FH TERB2 | 3.92e-05 | 648 | 125 | 14 | GO:0006281 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | ROCK2 NUSAP1 TICRR CENPE VPS4A TMOD3 MCM4 SMC2 MAP10 USP8 SETD2 BRCA2 ARHGEF10 RMDN1 BRD7 SMARCC1 KIF11 KNL1 | 4.00e-05 | 1014 | 125 | 18 | GO:0000278 |
| GeneOntologyBiologicalProcess | nuclear division | NUSAP1 BRIP1 CENPE VPS4A SMC2 MAP10 BRCA2 ARHGEF10 RMDN1 TERB2 KIF11 KNL1 | 6.68e-05 | 512 | 125 | 12 | GO:0000280 |
| GeneOntologyBiologicalProcess | establishment of chromosome localization | 1.00e-04 | 122 | 125 | 6 | GO:0051303 | |
| GeneOntologyBiologicalProcess | meiotic chromosome segregation | 1.00e-04 | 122 | 125 | 6 | GO:0045132 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle process | 1.08e-04 | 307 | 125 | 9 | GO:0090068 | |
| GeneOntologyBiologicalProcess | homologous chromosome orientation in meiotic metaphase I | 1.09e-04 | 3 | 125 | 2 | GO:0031619 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | ROCK2 NUSAP1 MAP1A CENPE MAP10 CCDC88C NCOR1 SETD2 BRCA2 ARHGEF10 RMDN1 PLK4 KIF11 JHY | 1.20e-04 | 720 | 125 | 14 | GO:0000226 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.25e-04 | 127 | 125 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | mitotic nuclear division | 1.34e-04 | 316 | 125 | 9 | GO:0140014 | |
| GeneOntologyBiologicalProcess | chromosome localization | 1.42e-04 | 130 | 125 | 6 | GO:0050000 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization involved in mitosis | 1.46e-04 | 187 | 125 | 7 | GO:1902850 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | MYH7 CENPE TMOD3 TMOD2 MAP10 NCOR1 MDN1 ARHGEF10 EIF2A PLK4 KIF11 | 1.51e-04 | 475 | 125 | 11 | GO:0140694 |
| GeneOntologyBiologicalProcess | double-strand break repair | 1.62e-04 | 324 | 125 | 9 | GO:0006302 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | METTL3 RRP8 MSL1 JMJD1C NSD3 TASOR2 SETD2 BRCA2 KMT5B BRD7 SMARCA1 SMARCC1 NCOA1 TOP1 | 1.62e-04 | 741 | 125 | 14 | GO:0006338 |
| GeneOntologyBiologicalProcess | organelle fission | NUSAP1 BRIP1 CENPE VPS4A SMC2 MAP10 BRCA2 ARHGEF10 RMDN1 TERB2 KIF11 KNL1 | 1.86e-04 | 571 | 125 | 12 | GO:0048285 |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 1.89e-04 | 407 | 125 | 10 | GO:0045787 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 2.08e-04 | 89 | 125 | 5 | GO:1901880 | |
| GeneOntologyBiologicalProcess | cellular response to Thyroglobulin triiodothyronine | 2.17e-04 | 4 | 125 | 2 | GO:1904017 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 2.47e-04 | 144 | 125 | 6 | GO:0051261 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 3.42e-04 | 99 | 125 | 5 | GO:0045104 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 3.43e-04 | 153 | 125 | 6 | GO:0030048 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 3.59e-04 | 100 | 125 | 5 | GO:0043242 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 3.59e-04 | 100 | 125 | 5 | GO:0045103 | |
| GeneOntologyBiologicalProcess | meiotic metaphase I homologous chromosome alignment | 3.60e-04 | 5 | 125 | 2 | GO:0043060 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 4.49e-04 | 105 | 125 | 5 | GO:1901879 | |
| GeneOntologyBiologicalProcess | metaphase chromosome alignment | 4.90e-04 | 107 | 125 | 5 | GO:0051310 | |
| GeneOntologyBiologicalProcess | muscle system process | ARHGAP42 ROCK2 MYH7 MYH8 DSP MYH7B TMOD3 TMOD2 TBX20 UTRN RNF207 | 5.02e-04 | 547 | 125 | 11 | GO:0003012 |
| GeneOntologyBiologicalProcess | meiotic metaphase chromosome alignment | 5.38e-04 | 6 | 125 | 2 | GO:0051311 | |
| GeneOntologyBiologicalProcess | response to Thyroglobulin triiodothyronine | 5.38e-04 | 6 | 125 | 2 | GO:1904016 | |
| GeneOntologyBiologicalProcess | DNA damage response | TICRR METTL3 BRIP1 PARG MCM4 RFC1 SMC2 SETD2 BRCA2 KMT5B BRD7 SMARCC1 BOD1L1 FH TERB2 | 7.01e-04 | 959 | 125 | 15 | GO:0006974 |
| GeneOntologyBiologicalProcess | pointed-end actin filament capping | 7.50e-04 | 7 | 125 | 2 | GO:0051694 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | MAP1A CENPE KIF21A DYNC2I1 CEP128 CCDC88C CFAP52 TEKT1 KIF11 JHY | 8.49e-04 | 493 | 125 | 10 | GO:0007018 |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 9.56e-04 | 124 | 125 | 5 | GO:0007229 | |
| GeneOntologyBiologicalProcess | regulation of thyroid hormone receptor signaling pathway | 9.96e-04 | 8 | 125 | 2 | GO:0002155 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ELOA BRIP1 CWC27 VPS4A AHCTF1 MCM4 RRP8 RFX5 PRPF40A JMJD1C NCOR1 R3HCC1L BRCA2 PES1 BRD7 SMARCA1 SMARCC1 NCOA1 BOD1L1 DDX41 COPS5 AFF4 | 3.07e-05 | 1377 | 128 | 22 | GO:0140513 |
| GeneOntologyCellularComponent | spindle pole | 3.90e-05 | 205 | 128 | 8 | GO:0000922 | |
| GeneOntologyCellularComponent | neuromuscular junction | 6.60e-05 | 112 | 128 | 6 | GO:0031594 | |
| GeneOntologyCellularComponent | supramolecular fiber | NUSAP1 MYH7 MYH8 MAP1A CENPE RIBC2 DSP MYH7B KIF21A TMOD3 TMOD2 MAP10 BFSP1 EFHC2 CFAP52 RMDN1 TEKT1 MACF1 KIF11 | 1.02e-04 | 1179 | 128 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | microtubule | NUSAP1 MAP1A CENPE RIBC2 KIF21A MAP10 EFHC2 CFAP52 RMDN1 TEKT1 MACF1 KIF11 | 1.08e-04 | 533 | 128 | 12 | GO:0005874 |
| GeneOntologyCellularComponent | laminin-10 complex | 1.11e-04 | 3 | 128 | 2 | GO:0043259 | |
| GeneOntologyCellularComponent | laminin-11 complex | 1.11e-04 | 3 | 128 | 2 | GO:0043260 | |
| GeneOntologyCellularComponent | supramolecular polymer | NUSAP1 MYH7 MYH8 MAP1A CENPE RIBC2 DSP MYH7B KIF21A TMOD3 TMOD2 MAP10 BFSP1 EFHC2 CFAP52 RMDN1 TEKT1 MACF1 KIF11 | 1.11e-04 | 1187 | 128 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | condensed chromosome | 1.17e-04 | 307 | 128 | 9 | GO:0000793 | |
| GeneOntologyCellularComponent | spindle | ROCK2 NUSAP1 CENPE VPS4A DYNC2I1 MAP10 CEP128 NCOR1 FRY RMDN1 KIF11 | 1.54e-04 | 471 | 128 | 11 | GO:0005819 |
| GeneOntologyCellularComponent | axonemal microtubule doublet inner sheath | 1.79e-04 | 46 | 128 | 4 | GO:0160110 | |
| GeneOntologyCellularComponent | A axonemal microtubule | 1.95e-04 | 47 | 128 | 4 | GO:0097649 | |
| GeneOntologyCellularComponent | nuclear matrix | 2.25e-04 | 140 | 128 | 6 | GO:0016363 | |
| GeneOntologyCellularComponent | axonemal doublet microtubule | 2.30e-04 | 49 | 128 | 4 | GO:0097545 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | NUSAP1 MAP1A CENPE RIBC2 DSP KIF21A TMOD3 MAP10 BFSP1 EFHC2 CFAP52 RMDN1 TEKT1 MACF1 KIF11 | 4.03e-04 | 899 | 128 | 15 | GO:0099513 |
| GeneOntologyCellularComponent | myosin filament | 4.67e-04 | 25 | 128 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | axonemal microtubule | 4.70e-04 | 59 | 128 | 4 | GO:0005879 | |
| GeneOntologyCellularComponent | myosin complex | 4.70e-04 | 59 | 128 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | nuclear periphery | 6.54e-04 | 171 | 128 | 6 | GO:0034399 | |
| GeneOntologyCellularComponent | myosin II complex | 6.57e-04 | 28 | 128 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | chromatin | TFEB VAX1 AHCTF1 PARG RRP8 MSL1 SMC2 RFX5 JMJD1C NSD3 NCOR1 ZFHX4 BRD7 SMARCA1 SMARCC1 NCOA1 ELF4 TBX20 COPS5 AFF4 | 6.66e-04 | 1480 | 128 | 20 | GO:0000785 |
| GeneOntologyCellularComponent | centrosome | ROCK2 TAPT1 ERC1 VPS4A CIR1 DYNC2I1 MAP10 CEP128 CCDC88C FRY BRCA2 ARHGEF10 PLK4 | 8.95e-04 | 770 | 128 | 13 | GO:0005813 |
| GeneOntologyCellularComponent | axonemal A tubule inner sheath | 9.77e-04 | 32 | 128 | 3 | GO:0160111 | |
| GeneOntologyCellularComponent | synaptic cleft | 1.07e-03 | 33 | 128 | 3 | GO:0043083 | |
| GeneOntologyCellularComponent | chromosomal region | 1.16e-03 | 421 | 128 | 9 | GO:0098687 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 1.22e-03 | 193 | 128 | 6 | GO:0000779 | |
| GeneOntologyCellularComponent | nuclear body | CASP8AP2 METTL3 ZC3H13 AHCTF1 PARG CIR1 MSL1 ERBIN PRPF40A PPIG TCERG1 AFDN ELF4 KNL1 | 1.28e-03 | 903 | 128 | 14 | GO:0016604 |
| GeneOntologyCellularComponent | RNA N6-methyladenosine methyltransferase complex | 1.30e-03 | 9 | 128 | 2 | GO:0036396 | |
| GeneOntologyCellularComponent | nuclear speck | 1.36e-03 | 431 | 128 | 9 | GO:0016607 | |
| GeneOntologyCellularComponent | cytoplasmic microtubule | 1.37e-03 | 133 | 128 | 5 | GO:0005881 | |
| GeneOntologyCellularComponent | mitotic spindle | 1.51e-03 | 201 | 128 | 6 | GO:0072686 | |
| GeneOntologyCellularComponent | microtubule organizing center | ROCK2 TAPT1 ERC1 VPS4A CIR1 DYNC2I1 MAP10 CEP128 EFHC2 CCDC88C FRY BRCA2 ARHGEF10 PLK4 | 1.51e-03 | 919 | 128 | 14 | GO:0005815 |
| GeneOntologyCellularComponent | laminin complex | 1.62e-03 | 10 | 128 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | cytoplasmic region | 1.71e-03 | 360 | 128 | 8 | GO:0099568 | |
| GeneOntologyCellularComponent | axoneme | 1.75e-03 | 207 | 128 | 6 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.79e-03 | 208 | 128 | 6 | GO:0097014 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 3.42e-03 | 317 | 128 | 7 | GO:0032838 | |
| GeneOntologyCellularComponent | RSC-type complex | 3.71e-03 | 15 | 128 | 2 | GO:0016586 | |
| GeneOntologyCellularComponent | muscle myosin complex | 4.22e-03 | 16 | 128 | 2 | GO:0005859 | |
| GeneOntologyCellularComponent | mitotic spindle midzone | 4.22e-03 | 16 | 128 | 2 | GO:1990023 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 4.76e-03 | 17 | 128 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | kinetochore | 5.17e-03 | 181 | 128 | 5 | GO:0000776 | |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | NUSAP1 CASP8AP2 TICRR METTL3 CENPE DSP AHCTF1 PARG LAMC1 MCM4 BRCA2 TLN1 PES1 SMARCC1 MACF1 ZFR FH COPS5 PLK4 TOP1 KIF11 KNL1 | 4.92e-08 | 772 | 105 | 22 | MP:0014259 |
| MousePheno | embryonic lethality prior to tooth bud stage | NUSAP1 EHBP1 TFEB CASP8AP2 TICRR METTL3 CENPE DSP ERC1 AHCTF1 PARG DYNC2I1 LAMC1 MCM4 RFC1 PRPF40A BRCA2 TLN1 PES1 SMARCC1 MACF1 AFDN ZFR FH DDX41 COPS5 PLK4 TOP1 KIF11 KNL1 | 5.61e-08 | 1383 | 105 | 30 | MP:0013293 |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | NUSAP1 CASP8AP2 TICRR METTL3 CENPE DSP AHCTF1 PARG LAMC1 MCM4 BRCA2 TLN1 PES1 SMARCC1 MACF1 ZFR FH COPS5 PLK4 TOP1 KIF11 KNL1 | 5.77e-08 | 779 | 105 | 22 | MP:0014257 |
| MousePheno | embryonic lethality between implantation and placentation, complete penetrance | METTL3 CENPE DSP AHCTF1 PARG LAMC1 MCM4 BRCA2 TLN1 SMARCC1 MACF1 ZFR FH COPS5 PLK4 KIF11 KNL1 | 2.07e-07 | 506 | 105 | 17 | MP:0011095 |
| MousePheno | embryonic lethality between implantation and somite formation, complete penetrance | CENPE DSP AHCTF1 PARG LAMC1 MCM4 SMARCC1 MACF1 FH COPS5 PLK4 KIF11 KNL1 | 5.67e-07 | 311 | 105 | 13 | MP:0011096 |
| MousePheno | embryonic lethality prior to organogenesis | NUSAP1 CASP8AP2 TICRR METTL3 CENPE DSP AHCTF1 PARG LAMC1 MCM4 RFC1 PRPF40A BRCA2 TLN1 PES1 SMARCC1 MACF1 AFDN ZFR FH DDX41 COPS5 PLK4 TOP1 KIF11 KNL1 | 6.06e-07 | 1204 | 105 | 26 | MP:0013292 |
| MousePheno | embryonic lethality between implantation and placentation | METTL3 CENPE DSP AHCTF1 PARG LAMC1 MCM4 BRCA2 TLN1 SMARCC1 MACF1 ZFR FH COPS5 PLK4 KIF11 KNL1 | 9.67e-07 | 565 | 105 | 17 | MP:0009850 |
| MousePheno | abnormal prenatal growth/weight/body size | NUSAP1 ELOA MYH8 TRIO DSP CWC27 VPS4A ZC3H13 ARHGEF12 LAMA5 DYNC2I1 LAMC1 MCM4 RRP8 RFC1 NCOR1 USP8 SETD2 TCERG1 BRCA2 TLN1 BRD7 AFDN ZFR TBX20 COPS5 PLK4 AFF4 KIF11 | 1.04e-06 | 1493 | 105 | 29 | MP:0004196 |
| MousePheno | embryonic lethality between implantation and somite formation | CENPE DSP AHCTF1 PARG LAMC1 MCM4 SMARCC1 MACF1 FH COPS5 PLK4 KIF11 KNL1 | 1.54e-06 | 340 | 105 | 13 | MP:0006205 |
| MousePheno | abnormal embryonic growth/weight/body size | NUSAP1 ELOA MYH8 TRIO DSP VPS4A ZC3H13 ARHGEF12 LAMA5 DYNC2I1 MCM4 RRP8 RFC1 NCOR1 USP8 SETD2 TCERG1 BRCA2 TLN1 AFDN ZFR TBX20 COPS5 PLK4 AFF4 KIF11 | 2.40e-06 | 1295 | 105 | 26 | MP:0002088 |
| MousePheno | abnormal embryo development | EHBP1 ELOA TICRR METTL3 DSP ZC3H13 PARG ARHGEF12 DYNC2I1 MCM4 RRP8 RFC1 USP8 SETD2 TCERG1 BRCA2 TLN1 PES1 MACF1 AFDN ZFR TBX20 COPS5 PLK4 AFF4 KIF11 | 6.76e-06 | 1370 | 105 | 26 | MP:0001672 |
| MousePheno | abnormal prenatal body size | NUSAP1 ELOA MYH8 TRIO DSP VPS4A ZC3H13 ARHGEF12 LAMA5 DYNC2I1 LAMC1 RRP8 RFC1 NCOR1 BRCA2 TLN1 BRD7 AFDN ZFR COPS5 PLK4 KIF11 | 2.27e-05 | 1116 | 105 | 22 | MP:0010866 |
| MousePheno | abnormal embryo size | NUSAP1 ELOA MYH8 TRIO DSP VPS4A ZC3H13 ARHGEF12 LAMA5 DYNC2I1 RRP8 RFC1 NCOR1 BRCA2 TLN1 AFDN ZFR COPS5 PLK4 KIF11 | 2.47e-05 | 956 | 105 | 20 | MP:0001697 |
| Domain | Spectrin_repeat | 1.35e-06 | 29 | 126 | 5 | IPR002017 | |
| Domain | SPEC | 2.25e-06 | 32 | 126 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.25e-06 | 32 | 126 | 5 | IPR018159 | |
| Domain | Spectrin | 1.58e-05 | 23 | 126 | 4 | PF00435 | |
| Domain | LAMININ_IVA | 1.64e-05 | 8 | 126 | 3 | PS51115 | |
| Domain | Laminin_B | 1.64e-05 | 8 | 126 | 3 | PF00052 | |
| Domain | LamB | 1.64e-05 | 8 | 126 | 3 | SM00281 | |
| Domain | Laminin_IV | 1.64e-05 | 8 | 126 | 3 | IPR000034 | |
| Domain | Myosin_N | 1.29e-04 | 15 | 126 | 3 | PF02736 | |
| Domain | Myosin_N | 1.29e-04 | 15 | 126 | 3 | IPR004009 | |
| Domain | Laminin_N | 1.57e-04 | 16 | 126 | 3 | IPR008211 | |
| Domain | LamNT | 1.57e-04 | 16 | 126 | 3 | SM00136 | |
| Domain | LAMININ_NTER | 1.57e-04 | 16 | 126 | 3 | PS51117 | |
| Domain | Laminin_N | 1.57e-04 | 16 | 126 | 3 | PF00055 | |
| Domain | Myosin_tail_1 | 2.27e-04 | 18 | 126 | 3 | PF01576 | |
| Domain | Myosin_tail | 2.27e-04 | 18 | 126 | 3 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 2.68e-04 | 19 | 126 | 3 | IPR027401 | |
| Domain | - | 2.68e-04 | 19 | 126 | 3 | 4.10.270.10 | |
| Domain | - | 2.69e-04 | 4 | 126 | 2 | 1.10.10.440 | |
| Domain | WW | 2.81e-04 | 47 | 126 | 4 | PF00397 | |
| Domain | WW | 3.05e-04 | 48 | 126 | 4 | SM00456 | |
| Domain | WW_DOMAIN_1 | 3.86e-04 | 51 | 126 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 3.86e-04 | 51 | 126 | 4 | PS50020 | |
| Domain | WW_dom | 4.16e-04 | 52 | 126 | 4 | IPR001202 | |
| Domain | AWS | 4.46e-04 | 5 | 126 | 2 | SM00570 | |
| Domain | Laminin_domII | 4.46e-04 | 5 | 126 | 2 | IPR010307 | |
| Domain | AWS | 4.46e-04 | 5 | 126 | 2 | PS51215 | |
| Domain | AWS_dom | 4.46e-04 | 5 | 126 | 2 | IPR006560 | |
| Domain | Laminin_aI | 4.46e-04 | 5 | 126 | 2 | IPR009254 | |
| Domain | Laminin_I | 4.46e-04 | 5 | 126 | 2 | PF06008 | |
| Domain | Laminin_II | 4.46e-04 | 5 | 126 | 2 | PF06009 | |
| Domain | ACTININ_2 | 4.81e-04 | 23 | 126 | 3 | PS00020 | |
| Domain | ACTININ_1 | 4.81e-04 | 23 | 126 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 4.81e-04 | 23 | 126 | 3 | IPR001589 | |
| Domain | PH | 6.02e-04 | 278 | 126 | 8 | SM00233 | |
| Domain | PH_DOMAIN | 6.16e-04 | 279 | 126 | 8 | PS50003 | |
| Domain | PH_dom-like | ARHGAP42 ROCK2 ARHGEF28 TRIO ARHGAP10 SPTBN2 ARHGEF12 ARHGEF10 TLN1 ARAP2 | 6.28e-04 | 426 | 126 | 10 | IPR011993 |
| Domain | PH_domain | 6.31e-04 | 280 | 126 | 8 | IPR001849 | |
| Domain | - | 6.65e-04 | 6 | 126 | 2 | 3.90.1290.10 | |
| Domain | FF_domain | 6.65e-04 | 6 | 126 | 2 | IPR002713 | |
| Domain | FF | 6.65e-04 | 6 | 126 | 2 | PS51676 | |
| Domain | FF | 6.65e-04 | 6 | 126 | 2 | PF01846 | |
| Domain | FF | 6.65e-04 | 6 | 126 | 2 | SM00441 | |
| Domain | SANT_dom | 6.96e-04 | 26 | 126 | 3 | IPR017884 | |
| Domain | RhoGAP | 8.14e-04 | 62 | 126 | 4 | SM00324 | |
| Domain | RhoGAP | 8.65e-04 | 63 | 126 | 4 | PF00620 | |
| Domain | DH_1 | 8.65e-04 | 63 | 126 | 4 | PS00741 | |
| Domain | SANT | 8.68e-04 | 28 | 126 | 3 | PS51293 | |
| Domain | BRCT_dom | 8.68e-04 | 28 | 126 | 3 | IPR001357 | |
| Domain | RhoGAP_dom | 9.18e-04 | 64 | 126 | 4 | IPR000198 | |
| Domain | RHOGAP | 9.18e-04 | 64 | 126 | 4 | PS50238 | |
| Domain | - | 9.18e-04 | 64 | 126 | 4 | 1.10.555.10 | |
| Domain | TMOD | 9.27e-04 | 7 | 126 | 2 | IPR004934 | |
| Domain | Plectin | 9.27e-04 | 7 | 126 | 2 | PF00681 | |
| Domain | Tropomodulin | 9.27e-04 | 7 | 126 | 2 | PF03250 | |
| Domain | Plectin_repeat | 9.27e-04 | 7 | 126 | 2 | IPR001101 | |
| Domain | PLEC | 9.27e-04 | 7 | 126 | 2 | SM00250 | |
| Domain | CH | 9.73e-04 | 65 | 126 | 4 | SM00033 | |
| Domain | EGF_LAM_2 | 1.07e-03 | 30 | 126 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.07e-03 | 30 | 126 | 3 | PS01248 | |
| Domain | RhoGEF | 1.15e-03 | 68 | 126 | 4 | SM00325 | |
| Domain | RhoGEF | 1.28e-03 | 70 | 126 | 4 | PF00621 | |
| Domain | CH | 1.28e-03 | 70 | 126 | 4 | PF00307 | |
| Domain | DH_2 | 1.28e-03 | 70 | 126 | 4 | PS50010 | |
| Domain | - | ARHGAP42 ROCK2 ARHGEF28 TRIO ARHGAP10 SPTBN2 ARHGEF12 TLN1 ARAP2 | 1.35e-03 | 391 | 126 | 9 | 2.30.29.30 |
| Domain | - | 1.35e-03 | 71 | 126 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 1.35e-03 | 71 | 126 | 4 | IPR000219 | |
| Domain | - | 1.35e-03 | 71 | 126 | 4 | 1.10.418.10 | |
| Domain | CH | 1.50e-03 | 73 | 126 | 4 | PS50021 | |
| Domain | CH-domain | 1.66e-03 | 75 | 126 | 4 | IPR001715 | |
| Domain | EGF_Lam | 1.68e-03 | 35 | 126 | 3 | SM00180 | |
| Domain | Laminin_EGF | 1.68e-03 | 35 | 126 | 3 | PF00053 | |
| Domain | P-loop_NTPase | MYH7 MYH8 BRIP1 CENPE MYH7B VPS4A KIF21A MCM4 RFC1 SMC2 MDN1 SMARCA1 DDX41 KIF11 | 1.75e-03 | 848 | 126 | 14 | IPR027417 |
| Domain | Myosin_head_motor_dom | 2.13e-03 | 38 | 126 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.13e-03 | 38 | 126 | 3 | PS51456 | |
| Domain | Myosin_head | 2.13e-03 | 38 | 126 | 3 | PF00063 | |
| Domain | Laminin_EGF | 2.13e-03 | 38 | 126 | 3 | IPR002049 | |
| Domain | MYSc | 2.13e-03 | 38 | 126 | 3 | SM00242 | |
| Domain | GDS_CDC24_CS | 2.29e-03 | 39 | 126 | 3 | IPR001331 | |
| Domain | SET | 2.65e-03 | 41 | 126 | 3 | PF00856 | |
| Domain | Kinesin_motor_CS | 2.65e-03 | 41 | 126 | 3 | IPR019821 | |
| Domain | Rho_GTPase_activation_prot | 2.98e-03 | 88 | 126 | 4 | IPR008936 | |
| Domain | Kinesin-like_fam | 3.04e-03 | 43 | 126 | 3 | IPR027640 | |
| Domain | - | 3.24e-03 | 44 | 126 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 3.24e-03 | 44 | 126 | 3 | PF00225 | |
| Domain | KISc | 3.24e-03 | 44 | 126 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 3.24e-03 | 44 | 126 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 3.24e-03 | 44 | 126 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 3.24e-03 | 44 | 126 | 3 | PS50067 | |
| Domain | I-BAR_dom | 3.35e-03 | 13 | 126 | 2 | IPR013606 | |
| Domain | SET | 3.68e-03 | 46 | 126 | 3 | SM00317 | |
| Domain | PH | 4.62e-03 | 229 | 126 | 6 | PF00169 | |
| Domain | SET_dom | 4.66e-03 | 50 | 126 | 3 | IPR001214 | |
| Domain | SANT | 4.66e-03 | 50 | 126 | 3 | SM00717 | |
| Domain | SET | 4.66e-03 | 50 | 126 | 3 | PS50280 | |
| Domain | Post-SET_dom | 5.09e-03 | 16 | 126 | 2 | IPR003616 | |
| Domain | PostSET | 5.09e-03 | 16 | 126 | 2 | SM00508 | |
| Domain | POST_SET | 5.09e-03 | 16 | 126 | 2 | PS50868 | |
| Domain | SANT/Myb | 5.21e-03 | 52 | 126 | 3 | IPR001005 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | ARHGAP42 ROCK2 ARHGEF28 TRIO ARHGAP10 ARHGEF12 ERBIN ARHGEF10 ARAP2 | 5.10e-07 | 142 | 96 | 9 | MM15576 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | ARHGAP42 ROCK2 ARHGEF28 TRIO ARHGAP10 ARHGEF12 ERBIN ARHGEF10 ARAP2 | 7.66e-07 | 149 | 96 | 9 | M41805 |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 3.44e-06 | 94 | 96 | 7 | MM15598 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP42 ROCK2 ARHGEF28 TRIO DSP ARHGAP10 ARHGEF12 TMOD3 FAM13B ERBIN ARHGEF10 ARAP2 | 4.19e-05 | 439 | 96 | 12 | MM15595 |
| Pathway | PID_INTEGRIN4_PATHWAY | 4.85e-05 | 11 | 96 | 3 | M158 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP42 ROCK2 ARHGEF28 TRIO DSP ARHGAP10 ARHGEF12 TMOD3 FAM13B ERBIN ARHGEF10 ARAP2 | 5.32e-05 | 450 | 96 | 12 | M27078 |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 7.89e-05 | 65 | 96 | 5 | M39682 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 8.49e-05 | 66 | 96 | 5 | MM15925 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 8.92e-05 | 155 | 96 | 7 | M41808 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP42 ROCK2 ARHGEF28 TRIO CENPE DSP ARHGAP10 AHCTF1 ARHGEF12 TMOD3 FAM13B ERBIN ARHGEF10 ARAP2 KNL1 | 9.98e-05 | 720 | 96 | 15 | M41838 |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 1.05e-04 | 69 | 96 | 5 | MM15596 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 1.12e-04 | 70 | 96 | 5 | M41806 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 1.12e-04 | 70 | 96 | 5 | MM15597 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP42 ROCK2 ARHGEF28 TRIO CENPE DSP ARHGAP10 AHCTF1 ARHGEF12 TMOD3 FAM13B ERBIN ARHGEF10 ARAP2 | 1.21e-04 | 649 | 96 | 14 | MM15690 |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 1.47e-04 | 74 | 96 | 5 | M41807 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.90e-04 | 175 | 96 | 7 | MM15599 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.90e-04 | 175 | 96 | 7 | MM14941 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 2.58e-04 | 184 | 96 | 7 | M41809 | |
| Pathway | PID_RHOA_REG_PATHWAY | 2.65e-04 | 46 | 96 | 4 | M68 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 5.30e-04 | 272 | 96 | 8 | M29619 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 5.58e-04 | 24 | 96 | 3 | M13404 | |
| Pathway | REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION | 9.84e-04 | 29 | 96 | 3 | M29808 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.09e-03 | 30 | 96 | 3 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.09e-03 | 30 | 96 | 3 | M27216 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ELOA BRIP1 DSP ZC3H13 AHCTF1 BCORL1 MCM4 RRP8 MSL1 RFC1 RFX5 PRPF40A JMJD1C NKRF HMGB1P1 NSD3 TASOR2 NCOR1 SETD2 TCERG1 BRCA2 BRD7 SMARCC1 AFDN ZFR BOD1L1 DDX41 TOP1 AFF4 KNL1 NOL8 | 1.94e-20 | 954 | 131 | 31 | 36373674 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EHBP1 ELOA MAP1A DSP ERC1 AHCTF1 PARG TMOD3 MCM4 RFC1 ERBIN PRPF40A NKRF USP8 SETD2 R3HCC1L TCERG1 TLN1 PES1 MACF1 ZFR BOD1L1 EIF2A UTRN TOP1 AFF4 KIF11 KNL1 NOL8 | 1.33e-18 | 934 | 131 | 29 | 33916271 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NUSAP1 TFEB CASP8AP2 TICRR DSP ZC3H13 AHCTF1 BCORL1 RRP8 MSL1 RFC1 SMC2 RFX5 PRPF40A JMJD1C NKRF ZBTB14 NSD3 NCOR1 PPIG SETD2 MDN1 TCERG1 USP42 SMARCC1 ZFR ELF4 DDX41 TOP1 NOL8 | 8.63e-16 | 1294 | 131 | 30 | 30804502 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | NUSAP1 ELOA BRIP1 CWC27 AHCTF1 BCORL1 MSL1 RFC1 RFX5 JMJD1C NSD3 PES1 BRD7 SMARCA1 SMARCC1 BOD1L1 ZBTB11 DDX41 TOP1 AFF4 RBM34 BRWD1 | 1.32e-15 | 608 | 131 | 22 | 36089195 |
| Pubmed | DSP ZC3H13 AHCTF1 SPTBN2 MCM4 RRP8 RFC1 PRPF40A NKRF TASOR2 MDN1 TLN1 PES1 SMARCC1 MACF1 AFDN ZFR FH ZBTB11 UTRN TOP1 RBM34 | 5.69e-15 | 653 | 131 | 22 | 22586326 | |
| Pubmed | ROCK2 RPGRIP1 ELOA MYH7 MYH8 DSP COL20A1 CWC27 MYH7B ERC1 KIF21A SPTBN2 MSL1 SMC2 CEP128 ERBIN TASOR2 NCOR1 USP8 MDN1 PES1 SMARCA1 SMARCC1 MACF1 ZFR BOD1L1 ZBTB11 TOP1 KIF11 DOP1A | 1.50e-14 | 1442 | 131 | 30 | 35575683 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | EHBP1 TFEB ARHGEF28 TRIO DSP ERC1 LAMC1 ERBIN TMCC3 NSD3 CCDC88C USP8 MDN1 TCERG1 ARHGEF10 MACF1 AFDN BOD1L1 DDX41 UTRN PLK4 KIF11 ARAP2 DOP1A | 1.87e-14 | 861 | 131 | 24 | 36931259 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NUSAP1 ELOA DSP CWC27 MCM4 RRP8 RFC1 ERBIN PRPF40A JMJD1C NKRF MDN1 TCERG1 USP42 PES1 SMARCC1 ZFR BOD1L1 ZBTB11 DDX41 TOP1 AFF4 KNL1 NOL8 | 3.69e-13 | 989 | 131 | 24 | 36424410 |
| Pubmed | MAP1A RIBC2 ARHGAP10 ERC1 VPS4A AHCTF1 TMOD3 PRPF40A NKRF NSD3 SETD2 ZFHX4 KMT5B CBY2 BRD7 SMARCA1 SMARCC1 TEKT1 MACF1 DDX41 TOP1 AFF4 ARAP2 KNL1 BRWD1 | 6.51e-13 | 1116 | 131 | 25 | 31753913 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ROCK2 DSP ERC1 ZC3H13 KIF21A SPTBN2 LAMC1 MCM4 SMC2 PRPF40A HMGB1P1 MDN1 TCERG1 TLN1 SMARCC1 MACF1 ZFR BOD1L1 UTRN TOP1 DOP1A BRWD1 | 1.05e-12 | 847 | 131 | 22 | 35235311 |
| Pubmed | DSP ERC1 AHCTF1 SPTBN2 SMC2 ERBIN PRPF40A JMJD1C NKRF NSD3 NCOR1 SETD2 TCERG1 TLN1 SMARCC1 AFDN ZFR BOD1L1 | 3.21e-12 | 549 | 131 | 18 | 38280479 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NUSAP1 ELOA METTL3 DSP ERC1 ZC3H13 AHCTF1 SPTBN2 TMOD3 RRP8 RFC1 SMC2 NKRF NSD3 TASOR2 TCERG1 PES1 SMARCA1 ZFR EIF2A DDX41 TOP1 RBM34 KIF11 NOL8 | 8.59e-12 | 1257 | 131 | 25 | 36526897 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | NUSAP1 AHCTF1 RRP8 MSL1 NKRF NSD3 PPIG TLN1 BRD7 SMARCC1 ELF4 DDX41 TOP1 RBM34 KIF11 | 1.19e-11 | 370 | 131 | 15 | 22922362 |
| Pubmed | ROCK2 EHBP1 DSP ERC1 AHCTF1 ARHGEF12 TMOD3 MCM4 SMC2 ERBIN PRPF40A JMJD1C TCERG1 TLN1 MACF1 AFDN BOD1L1 EIF2A TOP1 | 2.43e-11 | 708 | 131 | 19 | 39231216 | |
| Pubmed | NUSAP1 CASP8AP2 ELOA METTL3 MCM4 RFC1 SMC2 PRPF40A NKRF NSD3 NCOR1 PPIG SETD2 MDN1 TCERG1 PES1 SMARCC1 ZFR BOD1L1 EIF2A DDX41 TOP1 | 3.44e-11 | 1014 | 131 | 22 | 32416067 | |
| Pubmed | ROCK2 TRIO CENPE ERC1 KIF21A SPTBN2 ARHGEF12 SMC2 ERBIN CCDC88C NCOR1 FRY MDN1 TAX1BP1 BRD7 SMARCC1 MACF1 AFDN ZFR AFF4 KIF11 | 9.22e-11 | 963 | 131 | 21 | 28671696 | |
| Pubmed | NUSAP1 BCORL1 TMOD3 TMOD2 MSL1 RFC1 RFX5 ERBIN PRPF40A JMJD1C NKRF ZBTB14 NCOR1 ZFHX4 TCERG1 PES1 BRD7 SMARCA1 SMARCC1 NCOA1 ZFR ELF4 TOP1 RBM34 FILIP1L | 1.30e-10 | 1429 | 131 | 25 | 35140242 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DSP VPS4A AHCTF1 KIF21A MCM4 RFC1 SMC2 ERBIN NKRF MDN1 TCERG1 TLN1 PES1 SMARCA1 SMARCC1 MACF1 AFDN ZFR EIF2A DDX41 UTRN TOP1 RBM34 KIF11 | 2.43e-10 | 1353 | 131 | 24 | 29467282 |
| Pubmed | NUSAP1 METTL3 ARHGAP10 CWC27 AHCTF1 ARHGEF12 LAMA5 RRP8 MSL1 ERBIN NKRF NSD3 SETD2 MDN1 TCERG1 TLN1 PES1 BRD7 MACF1 AFDN EIF2A ZBTB11 UTRN AFF4 NOL8 | 3.41e-10 | 1497 | 131 | 25 | 31527615 | |
| Pubmed | ZC3H13 AHCTF1 TMOD3 LAMA5 RRP8 RFC1 SMC2 PRPF40A NKRF NSD3 NCOR1 MDN1 TCERG1 JRK PES1 ZFR TOP1 RBM34 NOL8 | 4.95e-10 | 847 | 131 | 19 | 35850772 | |
| Pubmed | EHBP1 CASP8AP2 DSP ERC1 BCORL1 LAMC1 JMJD1C NCOR1 ZFHX4 BRCA2 ZBTB11 UTRN KIF11 KNL1 | 7.23e-10 | 418 | 131 | 14 | 34709266 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ROCK2 METTL3 DSP KIF21A TMOD3 SMC2 PRPF40A MDN1 TLN1 BRD7 MACF1 DDX41 COPS5 TOP1 KIF11 KNL1 | 7.25e-10 | 582 | 131 | 16 | 20467437 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ROCK2 ELOA BRIP1 DSP ZC3H13 PARG MCM4 RFC1 ERBIN PRPF40A NCOR1 PPIG SETD2 MDN1 USP42 SMARCC1 AFDN DDX41 | 8.37e-10 | 774 | 131 | 18 | 15302935 |
| Pubmed | NUSAP1 ELOA DSP AHCTF1 SPTBN2 LAMC1 RRP8 MSL1 RFC1 PRPF40A NKRF PPIG TCERG1 TLN1 TAX1BP1 PES1 BRD7 SMARCA1 SMARCC1 DDX41 TOP1 AFF4 RBM34 | 1.76e-09 | 1371 | 131 | 23 | 36244648 | |
| Pubmed | ZCWPW2 AHCTF1 MCM4 RFC1 SMC2 NKRF TASOR2 USP42 PES1 BRD7 SMARCA1 SMARCC1 BOD1L1 EIF2A | 3.16e-09 | 469 | 131 | 14 | 27634302 | |
| Pubmed | NUSAP1 BCORL1 MCM4 RFC1 SMC2 RFX5 JMJD1C NCOR1 TCERG1 TLN1 PES1 SMARCC1 NCOA1 ZFR EIF2A DDX41 COPS5 TOP1 KIF11 KNL1 | 6.31e-09 | 1103 | 131 | 20 | 34189442 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | AHCTF1 MCM4 RFC1 SMC2 TASOR2 TCERG1 PES1 SMARCA1 SMARCC1 ZFR NOL8 | 7.29e-09 | 271 | 131 | 11 | 32433965 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | ELOA DSP ZC3H13 RFC1 PRPF40A NKRF MDN1 ZFHX4 PES1 SMARCA1 SMARCC1 ZFR DDX41 TOP1 RBM34 | 1.02e-08 | 605 | 131 | 15 | 28977666 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | ELOA AHCTF1 RFC1 JMJD1C NCOR1 TCERG1 ZFR BOD1L1 TOP1 AFF4 NOL8 | 1.14e-08 | 283 | 131 | 11 | 30585729 |
| Pubmed | ELOA VPS4A ZC3H13 SPTBN2 TMOD3 RRP8 RFC1 PRPF40A NKRF PPIG PES1 ZFR EIF2A DDX41 TOP1 RBM34 | 1.28e-08 | 713 | 131 | 16 | 29802200 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRIO DSP VPS4A RGS22 MCM4 RFC1 SMC2 PRPF40A MDN1 TCERG1 TLN1 PES1 SMARCA1 SMARCC1 AFDN ZFR BOD1L1 FH DDX41 TOP1 RBM34 KIF11 | 1.85e-08 | 1425 | 131 | 22 | 30948266 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NUSAP1 ELOA TICRR CENPE RRP8 RFC1 SMC2 NKRF MDN1 TCERG1 MACF1 ZFR ZBTB11 TOP1 RBM34 NOL8 | 3.05e-08 | 759 | 131 | 16 | 35915203 |
| Pubmed | 3.46e-08 | 183 | 131 | 9 | 36129980 | ||
| Pubmed | EHBP1 CASP8AP2 MAP1A DSP SPTBN2 FAM13B ERBIN NSD3 USF3 TCERG1 MACF1 MAPK10 COPS5 | 4.29e-08 | 486 | 131 | 13 | 20936779 | |
| Pubmed | ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress. | 4.33e-08 | 26 | 131 | 5 | 34162889 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | TFEB CASP8AP2 METTL3 MAP1A CENPE DSP ERC1 BCORL1 NCOR1 SETD2 TCERG1 BRCA2 MACF1 KNL1 | 5.35e-08 | 588 | 131 | 14 | 38580884 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYH7 DSP ERC1 VPS4A SPTBN2 TMOD3 MCM4 RFC1 SMC2 PRPF40A MDN1 TCERG1 TLN1 MACF1 AFDN EIF2A DDX41 TOP1 KIF11 | 6.68e-08 | 1149 | 131 | 19 | 35446349 |
| Pubmed | TRIO DSP ERC1 KIF21A SPTBN2 DYNC2I1 RFX5 BFSP1 USP8 FRY TCERG1 ARHGEF10 MACF1 AFDN ZBTB11 UTRN COPS5 TOP1 AFF4 BRWD1 | 7.78e-08 | 1285 | 131 | 20 | 35914814 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | TICRR CENPE DSP ZC3H13 KIF21A SPTBN2 BCORL1 FRY R3HCC1L MDN1 TLN1 BOD1L1 ZBTB11 UTRN SERPINA9 | 1.31e-07 | 736 | 131 | 15 | 29676528 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | CENPE CWC27 ERC1 ZC3H13 ARHGEF12 JMJD1C PPIG ZFHX4 MACF1 TOP1 KIF11 | 1.35e-07 | 361 | 131 | 11 | 26167880 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ELOA MAP1A DSP ZC3H13 SPTBN2 PRPF40A NKRF NSD3 PPIG SETD2 TCERG1 USP42 PES1 SMARCC1 MACF1 DDX41 TOP1 AFF4 | 1.40e-07 | 1082 | 131 | 18 | 38697112 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TRIO CENPE DSP ERC1 SPTBN2 DYNC2I1 CEP128 CCDC88C NCOR1 PPIG BRCA2 TLN1 AFDN EIF2A DDX41 BRWD1 | 1.49e-07 | 853 | 131 | 16 | 28718761 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYH7 DSP ARHGAP10 PARG MCM4 SMC2 JMJD1C NKRF NCOR1 MDN1 ZFHX4 TCERG1 PES1 SMARCA1 SMARCC1 ZFR | 1.59e-07 | 857 | 131 | 16 | 25609649 |
| Pubmed | NUSAP1 METTL3 ERC1 PARG BCORL1 MSL1 RFC1 RFX5 ERBIN NSD3 TLN1 TAX1BP1 UTRN KIF11 | 1.65e-07 | 645 | 131 | 14 | 25281560 | |
| Pubmed | 2.81e-07 | 234 | 131 | 9 | 36243803 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DSP SPTBN2 TMOD3 LAMC1 MCM4 SMC2 PRPF40A NKRF MDN1 TLN1 PES1 MACF1 AFDN ZFR DDX41 UTRN TOP1 | 3.31e-07 | 1024 | 131 | 17 | 24711643 |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 3.64e-07 | 316 | 131 | 10 | 31665637 | |
| Pubmed | MAP1A ARHGAP10 SPTBN2 LAMA5 RFC1 TASOR2 SETD2 PES1 MACF1 ZFR AFF4 RBM34 | 4.24e-07 | 496 | 131 | 12 | 31343991 | |
| Pubmed | MYH7 MYH8 TRIO DSP LAMA2 LAMC1 JMJD1C NCOR1 TLN1 TAX1BP1 MACF1 UTRN | 4.34e-07 | 497 | 131 | 12 | 23414517 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | NUSAP1 AHCTF1 SMC2 PRPF40A TASOR2 NCOR1 PPIG TCERG1 SMARCA1 SMARCC1 TOP1 | 4.90e-07 | 411 | 131 | 11 | 35182466 |
| Pubmed | 5.19e-07 | 5 | 131 | 3 | 11969289 | ||
| Pubmed | 5.23e-07 | 78 | 131 | 6 | 28611094 | ||
| Pubmed | 5.92e-07 | 419 | 131 | 11 | 15635413 | ||
| Pubmed | ELOA BRIP1 TRIO CENPE TMOD3 DYNC2I1 ERBIN JMJD1C USP8 SETD2 ARHGEF10 PES1 BOD1L1 KNL1 | 7.63e-07 | 733 | 131 | 14 | 34672954 | |
| Pubmed | CASP8AP2 TAPT1 ZC3H13 AHCTF1 SPTBN2 LAMC1 RRP8 ERBIN PRPF40A TMCC3 R3HCC1L MDN1 ARHGEF10 TLN1 PES1 DNAJC5G MACF1 EIF2A RBM34 NOL8 | 7.83e-07 | 1487 | 131 | 20 | 33957083 | |
| Pubmed | BRIP1 TRIO SPTBN2 ERBIN NKRF MDN1 BRCA2 TLN1 BRD7 SMARCC1 MACF1 COPS5 RBM34 | 8.84e-07 | 634 | 131 | 13 | 34591612 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | METTL3 RFC1 PRPF40A NSD3 MDN1 TCERG1 KMT5B PES1 SMARCA1 SMARCC1 ZBTB11 TOP1 | 9.03e-07 | 533 | 131 | 12 | 30554943 |
| Pubmed | DSP AHCTF1 RFC1 SMC2 PRPF40A NKRF TCERG1 PES1 ZFR TOP1 KIF11 | 9.77e-07 | 441 | 131 | 11 | 31239290 | |
| Pubmed | CASP8AP2 MYH7 DSP CWC27 ERC1 TMOD3 LAMA5 MCM4 USP8 SETD2 BRCA2 JRK SMARCC1 ZFR | 1.06e-06 | 754 | 131 | 14 | 35906200 | |
| Pubmed | 1.09e-06 | 21 | 131 | 4 | 19596656 | ||
| Pubmed | 1.33e-06 | 282 | 131 | 9 | 23667531 | ||
| Pubmed | 1.42e-06 | 210 | 131 | 8 | 16565220 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | EHBP1 ERC1 SPTBN2 ARHGEF12 TMOD3 ERBIN USP8 TLN1 MACF1 AFDN EIF2A UTRN | 1.65e-06 | 565 | 131 | 12 | 25468996 |
| Pubmed | Abscence of laminin alpha1 chain in the skeletal muscle of dystrophic dy/dy mice. | 1.81e-06 | 7 | 131 | 3 | 9390664 | |
| Pubmed | 1.81e-06 | 7 | 131 | 3 | 14557481 | ||
| Pubmed | ROCK2 TRIO DSP KIF21A CIR1 LAMA5 LAMC1 RFC1 NSD3 NCOR1 TAX1BP1 PES1 MACF1 ZFR BOD1L1 TOP1 RBM34 KIF11 | 1.91e-06 | 1297 | 131 | 18 | 33545068 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 1.94e-06 | 219 | 131 | 8 | 31353912 | |
| Pubmed | The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. | 2.00e-06 | 220 | 131 | 8 | 31822558 | |
| Pubmed | 2.14e-06 | 222 | 131 | 8 | 37071664 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | ROCK2 ZC3H13 RRP8 PRPF40A NKRF PPIG TCERG1 PES1 MACF1 ZFR DDX41 TOP1 RBM34 NOL8 | 2.35e-06 | 807 | 131 | 14 | 22681889 |
| Pubmed | 2.35e-06 | 483 | 131 | 11 | 36912080 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ZC3H13 AHCTF1 MCM4 RFC1 SMC2 PRPF40A NKRF NCOR1 PPIG MDN1 TCERG1 USP42 PES1 SMARCC1 FH DDX41 TOP1 RBM34 | 2.39e-06 | 1318 | 131 | 18 | 30463901 |
| Pubmed | 2.61e-06 | 228 | 131 | 8 | 30471916 | ||
| Pubmed | LAMA5 LAMC1 ERBIN PRPF40A NCOR1 TAX1BP1 MACF1 AFDN ZBTB11 UTRN COPS5 KNL1 | 2.63e-06 | 591 | 131 | 12 | 15231748 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.66e-06 | 394 | 131 | 10 | 27248496 | |
| Pubmed | 2.88e-06 | 8 | 131 | 3 | 8872465 | ||
| Pubmed | 2.88e-06 | 8 | 131 | 3 | 9852162 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | ROCK2 AHCTF1 KIF21A SPTBN2 TMOD2 SMC2 CEP128 MACF1 BOD1L1 EIF2A TOP1 | 3.15e-06 | 498 | 131 | 11 | 36634849 |
| Pubmed | 3.24e-06 | 403 | 131 | 10 | 35253629 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ROCK2 DSP KIF21A LAMC1 RFC1 SMC2 ERBIN PRPF40A RMDN1 TLN1 SMARCC1 AFDN ZFR FH EIF2A UTRN KIF11 KNL1 | 3.96e-06 | 1367 | 131 | 18 | 32687490 |
| Pubmed | Study of FOXO1-interacting proteins using TurboID-based proximity labeling technology. | 4.18e-06 | 243 | 131 | 8 | 36964488 | |
| Pubmed | DSP ZC3H13 SPTBN2 SMC2 PRPF40A NKRF PPIG TCERG1 PES1 ZFR DDX41 TOP1 RBM34 | 4.21e-06 | 731 | 131 | 13 | 29298432 | |
| Pubmed | ROCK2 KIF21A TMOD3 MCM4 RFC1 SMC2 ERBIN PRPF40A NKRF NCOR1 PPIG TLN1 TAX1BP1 SMARCC1 FH TOP1 AFF4 | 4.78e-06 | 1247 | 131 | 17 | 27684187 | |
| Pubmed | A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy. | 4.84e-06 | 65 | 131 | 5 | 27453043 | |
| Pubmed | 5.15e-06 | 250 | 131 | 8 | 33536335 | ||
| Pubmed | 5.30e-06 | 251 | 131 | 8 | 31076518 | ||
| Pubmed | BCORL1 LAMC1 RRP8 RFC1 NCOR1 USP8 MDN1 APOL6 SMARCC1 NCOA1 RBM34 KNL1 | 5.72e-06 | 638 | 131 | 12 | 31182584 | |
| Pubmed | 6.05e-06 | 68 | 131 | 5 | 22779921 | ||
| Pubmed | Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. | 6.15e-06 | 10 | 131 | 3 | 18590826 | |
| Pubmed | 6.15e-06 | 10 | 131 | 3 | 11784026 | ||
| Pubmed | 6.15e-06 | 10 | 131 | 3 | 9034910 | ||
| Pubmed | 6.54e-06 | 538 | 131 | 11 | 28524877 | ||
| Pubmed | ROCK2 VPS4A PARG MCM4 SMC2 NKRF TLN1 ZFR EIF2A DDX41 COPS5 KIF11 | 7.22e-06 | 653 | 131 | 12 | 33742100 | |
| Pubmed | DSP CIR1 MSL1 RFC1 PRPF40A NKRF PPIG PES1 ZFR ZBTB11 DDX41 RBM34 | 7.45e-06 | 655 | 131 | 12 | 35819319 | |
| Pubmed | DSP ZC3H13 SPTBN2 NKRF TASOR2 CCDC88C ZFR FH TOP1 RBM34 KIF11 | 8.19e-06 | 551 | 131 | 11 | 34728620 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 8.43e-06 | 11 | 131 | 3 | 23472759 | |
| Pubmed | 8.43e-06 | 11 | 131 | 3 | 12051813 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 8.43e-06 | 11 | 131 | 3 | 21524702 | |
| Pubmed | 8.55e-06 | 268 | 131 | 8 | 33640491 | ||
| Pubmed | 9.03e-06 | 453 | 131 | 10 | 29656893 | ||
| Interaction | SMC5 interactions | ELOA BRIP1 DSP ZC3H13 AHCTF1 BCORL1 MCM4 RRP8 MSL1 RFC1 RFX5 PRPF40A JMJD1C NKRF HMGB1P1 NSD3 TASOR2 NCOR1 SETD2 TCERG1 BRCA2 BRD7 SMARCC1 AFDN ZFR BOD1L1 DDX41 TOP1 AFF4 KNL1 NOL8 | 1.40e-13 | 1000 | 129 | 31 | int:SMC5 |
| Interaction | NAA40 interactions | EHBP1 ELOA MAP1A DSP ERC1 AHCTF1 PARG TMOD3 MCM4 RFC1 ERBIN PRPF40A NKRF USP8 SETD2 R3HCC1L TCERG1 TLN1 PES1 MACF1 ZFR BOD1L1 EIF2A UTRN TOP1 AFF4 KIF11 KNL1 NOL8 | 2.99e-12 | 978 | 129 | 29 | int:NAA40 |
| Interaction | H3-3A interactions | NUSAP1 ELOA BRIP1 CWC27 AHCTF1 BCORL1 DYNC2I1 MSL1 RFC1 RFX5 JMJD1C NSD3 BRD7 SMARCA1 SMARCC1 BOD1L1 FH ZBTB11 DDX41 COPS5 TOP1 AFF4 RBM34 KIF11 BRWD1 | 9.74e-12 | 749 | 129 | 25 | int:H3-3A |
| Interaction | SNRNP40 interactions | CASP8AP2 BRIP1 ZC3H13 AHCTF1 MCM4 RFC1 PRPF40A NKRF NSD3 TASOR2 NCOR1 SETD2 TCERG1 BRCA2 USP42 SMARCA1 SMARCC1 ZBTB11 DDX41 COPS5 TOP1 KNL1 NOL8 | 1.54e-11 | 637 | 129 | 23 | int:SNRNP40 |
| Interaction | NUP43 interactions | CASP8AP2 BRIP1 DSP ZC3H13 AHCTF1 MSL1 RFC1 JMJD1C NKRF NSD3 TASOR2 NCOR1 SETD2 BRCA2 SMARCA1 SMARCC1 ELF4 BOD1L1 EIF2A ZBTB11 TOP1 KNL1 | 7.31e-11 | 625 | 129 | 22 | int:NUP43 |
| Interaction | SIRT7 interactions | DSP ZC3H13 AHCTF1 SPTBN2 MCM4 RRP8 RFC1 PRPF40A NKRF TASOR2 MDN1 TLN1 PES1 SMARCC1 MACF1 AFDN ZFR FH ZBTB11 UTRN COPS5 TOP1 RBM34 | 3.32e-10 | 744 | 129 | 23 | int:SIRT7 |
| Interaction | TERF2IP interactions | ELOA METTL3 BRIP1 CWC27 AHCTF1 RFC1 RFX5 PRPF40A NSD3 TASOR2 NCOR1 SETD2 TCERG1 BRCA2 SMARCA1 SMARCC1 BOD1L1 TOP1 AFF4 KNL1 | 3.55e-10 | 552 | 129 | 20 | int:TERF2IP |
| Interaction | H3C3 interactions | NUSAP1 ELOA BRIP1 CWC27 AHCTF1 BCORL1 MSL1 RFC1 RFX5 JMJD1C NSD3 PES1 BRD7 SMARCA1 SMARCC1 BOD1L1 TOP1 AFF4 RBM34 | 3.92e-10 | 495 | 129 | 19 | int:H3C3 |
| Interaction | H3C1 interactions | ROCK2 NUSAP1 ELOA BRIP1 DSP ARHGAP10 AHCTF1 LAMA2 MCM4 MSL1 RFC1 RFX5 JMJD1C NSD3 NCOR1 SETD2 PES1 BRD7 SMARCA1 ZFR TOP1 AFF4 RBM34 KIF11 JHY | 4.84e-10 | 901 | 129 | 25 | int:H3C1 |
| Interaction | ZNF330 interactions | NUSAP1 ELOA CWC27 BCORL1 MSL1 RFC1 NKRF NSD3 PES1 BRD7 SMARCA1 SMARCC1 ZBTB11 DDX41 TOP1 AFF4 RBM34 NOL8 | 5.33e-10 | 446 | 129 | 18 | int:ZNF330 |
| Interaction | FOXP3 interactions | NUSAP1 AHCTF1 RRP8 MSL1 SMC2 NKRF NSD3 PPIG TLN1 BRD7 SMARCC1 ZFR ELF4 DDX41 TOP1 RBM34 KIF11 | 2.45e-09 | 432 | 129 | 17 | int:FOXP3 |
| Interaction | KCNA3 interactions | ROCK2 EHBP1 DSP MYH7B ERC1 AHCTF1 ARHGEF12 TMOD3 MCM4 SMC2 ERBIN PRPF40A JMJD1C CCDC88C TCERG1 TLN1 MACF1 AFDN BOD1L1 EIF2A TOP1 KIF11 DOP1A | 6.77e-09 | 871 | 129 | 23 | int:KCNA3 |
| Interaction | H2BC21 interactions | ROCK2 TICRR AHCTF1 BCORL1 MCM4 MSL1 RFC1 SMC2 JMJD1C NSD3 USP8 USF3 USP42 TLN1 BRD7 SMARCA1 SMARCC1 EIF2A COPS5 TOP1 | 1.84e-08 | 696 | 129 | 20 | int:H2BC21 |
| Interaction | H2BC8 interactions | NUSAP1 ELOA METTL3 CWC27 AHCTF1 PARG BCORL1 MSL1 RFC1 RFX5 NSD3 TCERG1 JRK BRD7 SMARCA1 SMARCC1 TOP1 RBM34 | 2.89e-08 | 576 | 129 | 18 | int:H2BC8 |
| Interaction | MEN1 interactions | ZC3H13 AHCTF1 LAMA5 RRP8 RFC1 SMC2 ERBIN PRPF40A JMJD1C NKRF NSD3 NCOR1 MDN1 TCERG1 BRCA2 PES1 AFDN ZFR BOD1L1 DDX41 TOP1 AFF4 RBM34 NOL8 | 3.30e-08 | 1029 | 129 | 24 | int:MEN1 |
| Interaction | YWHAG interactions | EHBP1 TFEB TICRR ARHGEF28 DSP ERC1 ZC3H13 FAM13B ERBIN PRPF40A TMCC3 CCDC88C USP8 PPIG MDN1 TCERG1 MACF1 AFDN BOD1L1 FH DDX41 UTRN COPS5 PLK4 ARAP2 DOP1A | 7.76e-08 | 1248 | 129 | 26 | int:YWHAG |
| Interaction | APEX1 interactions | ROCK2 ELOA BRIP1 ARHGEF28 ERC1 AHCTF1 SPTBN2 BCORL1 RFC1 RFX5 NKRF ZBTB14 NSD3 SETD2 BRCA2 TLN1 TAX1BP1 PES1 SMARCA1 SMARCC1 EIF2A AFF4 KIF11 NOL8 FILIP1L BRWD1 | 1.11e-07 | 1271 | 129 | 26 | int:APEX1 |
| Interaction | YWHAH interactions | EHBP1 TFEB TICRR ARHGEF28 TRIO DSP ERC1 ZC3H13 CEP128 ERBIN TMCC3 NSD3 CCDC88C USP8 TCERG1 NCOA1 MACF1 AFDN BOD1L1 UTRN PLK4 KIF11 ARAP2 DOP1A | 1.19e-07 | 1102 | 129 | 24 | int:YWHAH |
| Interaction | KIF23 interactions | DSP ERC1 ZC3H13 LAMA2 TMOD3 RRP8 RFC1 SMC2 RFX5 PRPF40A NKRF USP8 PPIG FRY TAX1BP1 PES1 MACF1 DDX41 TOP1 AFF4 RBM34 KIF11 NOL8 | 1.48e-07 | 1031 | 129 | 23 | int:KIF23 |
| Interaction | SOX2 interactions | NUSAP1 TFEB ELOA MAP1A DSP SPTBN2 TMOD3 MSL1 RFC1 SMC2 JMJD1C NKRF NCOR1 SETD2 MDN1 ZFHX4 PES1 BRD7 SMARCC1 TEKT1 MACF1 ZFR BOD1L1 DDX41 TOP1 RBM34 KNL1 | 2.71e-07 | 1422 | 129 | 27 | int:SOX2 |
| Interaction | DDX23 interactions | ELOA CWC27 ZC3H13 MCM4 PRPF40A NKRF PPIG SETD2 TCERG1 PES1 DDX41 TOP1 AFF4 RBM34 NOL8 | 4.51e-07 | 480 | 129 | 15 | int:DDX23 |
| Interaction | CDC5L interactions | ROCK2 TRIO DSP CWC27 KIF21A TRIM31 TMOD3 MCM4 SMC2 PRPF40A MDN1 TLN1 BRD7 MACF1 DDX41 COPS5 TOP1 KIF11 KNL1 NOL8 | 5.12e-07 | 855 | 129 | 20 | int:CDC5L |
| Interaction | ASF1A interactions | CASP8AP2 BRIP1 ZC3H13 SPTBN2 BCORL1 MCM4 NSD3 TASOR2 NCOR1 BRCA2 SMARCC1 | 6.06e-07 | 249 | 129 | 11 | int:ASF1A |
| Interaction | PARP1 interactions | ELOA CWC27 PARG BCORL1 MCM4 RRP8 MSL1 RFC1 SMC2 RFX5 PRPF40A NKRF NSD3 MDN1 BRCA2 PES1 BRD7 SMARCA1 SMARCC1 DDX41 COPS5 TOP1 AFF4 RBM34 NOL8 | 8.10e-07 | 1316 | 129 | 25 | int:PARP1 |
| Interaction | CBX3 interactions | ELOA BRIP1 CWC27 ZC3H13 AHCTF1 BCORL1 MSL1 RFC1 NSD3 NCOR1 SETD2 TAX1BP1 SMARCA1 MACF1 TOP1 KNL1 NOL8 | 8.12e-07 | 646 | 129 | 17 | int:CBX3 |
| Interaction | CENPA interactions | ZC3H13 BCORL1 MCM4 RFC1 NSD3 PES1 BRD7 SMARCA1 SMARCC1 TOP1 RBM34 NOL8 BRWD1 | 9.30e-07 | 377 | 129 | 13 | int:CENPA |
| Interaction | HECTD1 interactions | NUSAP1 ELOA TICRR CENPE RRP8 RFC1 SMC2 PRPF40A NKRF MDN1 TCERG1 ARHGEF10 MACF1 ZFR ZBTB11 DDX41 UTRN COPS5 TOP1 RBM34 NOL8 | 1.14e-06 | 984 | 129 | 21 | int:HECTD1 |
| Interaction | SNRNP70 interactions | ELOA METTL3 VPS4A ZC3H13 SPTBN2 TRIM31 TMOD3 RRP8 RFC1 PRPF40A NKRF PPIG PES1 SMARCC1 ZFR EIF2A DDX41 COPS5 TOP1 RBM34 KIF11 | 1.14e-06 | 984 | 129 | 21 | int:SNRNP70 |
| Interaction | EED interactions | TRIO DSP ZC3H13 AHCTF1 TMOD3 LAMA5 LAMC1 MCM4 RRP8 SMC2 PRPF40A NKRF TASOR2 NCOR1 TCERG1 RMDN1 TLN1 PES1 SMARCA1 SMARCC1 MACF1 AFDN ZFR DDX41 TOP1 KIF11 | 1.30e-06 | 1445 | 129 | 26 | int:EED |
| Interaction | XRCC6 interactions | ELOA METTL3 CWC27 AHCTF1 TRIM31 TMOD3 RFC1 PRPF40A JMJD1C NCOR1 TCERG1 BRCA2 BRD7 ZFR BOD1L1 TBX20 COPS5 TOP1 AFF4 NOL8 | 1.82e-06 | 928 | 129 | 20 | int:XRCC6 |
| Interaction | HDAC1 interactions | EHBP1 CASP8AP2 MYH7 MYH8 METTL3 ERC1 MCM4 RFC1 SMC2 CEP128 JMJD1C NCOR1 ZFHX4 BRCA2 TLN1 TAX1BP1 SMARCC1 MAPK10 ZBTB11 UTRN COPS5 KNL1 | 2.01e-06 | 1108 | 129 | 22 | int:HDAC1 |
| Interaction | TOP1 interactions | METTL3 TRIM31 MCM4 RFC1 PRPF40A SETD2 TCERG1 BRCA2 TAX1BP1 PES1 BRD7 SMARCA1 SMARCC1 ZFR FH COPS5 TOP1 | 2.24e-06 | 696 | 129 | 17 | int:TOP1 |
| Interaction | YWHAQ interactions | TFEB TICRR MYH7 ARHGEF28 ARHGAP10 ERC1 ZC3H13 TRIM31 RFC1 ERBIN TMCC3 CCDC88C USP8 USP42 KMT5B TLN1 NCOA1 MACF1 AFDN PLK4 ARAP2 DOP1A | 2.33e-06 | 1118 | 129 | 22 | int:YWHAQ |
| Interaction | MAGEB2 interactions | RPGRIP1 RRP8 RFC1 NKRF PPIG USP42 BRD7 ZFR ZBTB11 TOP1 RBM34 NOL8 | 2.57e-06 | 349 | 129 | 12 | int:MAGEB2 |
| Interaction | LHX2 interactions | 2.77e-06 | 183 | 129 | 9 | int:LHX2 | |
| Interaction | YWHAZ interactions | TFEB ELOA TICRR ARHGEF28 CWC27 ERC1 SPTBN2 LAMC1 SMC2 FAM13B ERBIN TMCC3 CCDC88C NCOR1 USP8 KMT5B TAX1BP1 MACF1 AFDN FH COPS5 PLK4 KIF11 ARAP2 | 2.96e-06 | 1319 | 129 | 24 | int:YWHAZ |
| Interaction | RPS6 interactions | ROCK2 NUSAP1 ELOA TRIM31 RRP8 RFC1 NKRF NSD3 PES1 BRD7 ZFR EIF2A ZBTB11 DDX41 COPS5 TOP1 RBM34 KIF11 NOL8 | 2.99e-06 | 874 | 129 | 19 | int:RPS6 |
| Interaction | ADARB1 interactions | AHCTF1 MCM4 RRP8 RFC1 SMC2 NKRF TCERG1 PES1 SMARCA1 SMARCC1 ZFR ZBTB11 RBM34 NOL8 | 3.11e-06 | 489 | 129 | 14 | int:ADARB1 |
| Interaction | POLR1G interactions | ELOA CWC27 BCORL1 RFC1 NKRF NSD3 MDN1 PES1 SMARCA1 ZBTB11 TOP1 AFF4 RBM34 NOL8 | 3.11e-06 | 489 | 129 | 14 | int:POLR1G |
| Interaction | RCOR1 interactions | EHBP1 CASP8AP2 DSP ERC1 BCORL1 SMC2 JMJD1C NCOR1 ZFHX4 BRCA2 SMARCC1 ZBTB11 UTRN KNL1 | 3.50e-06 | 494 | 129 | 14 | int:RCOR1 |
| Interaction | SRSF6 interactions | ZC3H13 KIF21A TRIM31 RRP8 NKRF PPIG SETD2 TCERG1 BRD7 ZFR ZBTB11 COPS5 RBM34 NOL8 | 4.30e-06 | 503 | 129 | 14 | int:SRSF6 |
| Interaction | MECP2 interactions | NUSAP1 ELOA MAP1A DSP ZC3H13 SPTBN2 TMOD3 RRP8 PRPF40A NKRF NSD3 NCOR1 PPIG SETD2 TCERG1 USP42 PES1 SMARCC1 MACF1 DDX41 TOP1 AFF4 NOL8 | 6.63e-06 | 1287 | 129 | 23 | int:MECP2 |
| Interaction | WDR76 interactions | DSP CWC27 LAMA5 LAMC1 MCM4 RFC1 MDN1 BRD7 ZFR UTRN TOP1 KIF11 | 6.63e-06 | 383 | 129 | 12 | int:WDR76 |
| Interaction | RPL31 interactions | ELOA ZC3H13 TRIM31 RRP8 RFC1 NKRF NSD3 PES1 MACF1 ZFR ZBTB11 DDX41 COPS5 TOP1 RBM34 NOL8 | 7.30e-06 | 680 | 129 | 16 | int:RPL31 |
| Interaction | NPM1 interactions | ROCK2 MYH7 METTL3 DSP AHCTF1 BCORL1 TRIM31 RRP8 RFC1 NKRF SETD2 TCERG1 BRCA2 PES1 BRD7 ELF4 ZBTB11 UTRN COPS5 TOP1 RBM34 KIF11 | 7.35e-06 | 1201 | 129 | 22 | int:NPM1 |
| Interaction | SSRP1 interactions | ELOA ZC3H13 MCM4 RFC1 PRPF40A NCOR1 SETD2 TCERG1 BRCA2 BRD7 SMARCA1 SMARCC1 ZFR COPS5 TOP1 BRWD1 | 8.00e-06 | 685 | 129 | 16 | int:SSRP1 |
| Interaction | BAP1 interactions | MYH7 DSP ERC1 VPS4A ZC3H13 SPTBN2 TMOD3 MCM4 RFC1 SMC2 PRPF40A MDN1 TCERG1 BRCA2 TLN1 MACF1 AFDN ELF4 FH EIF2A DDX41 TOP1 KIF11 | 9.30e-06 | 1314 | 129 | 23 | int:BAP1 |
| Interaction | CEBPA interactions | NUSAP1 RPGRIP1 BCORL1 MCM4 RFC1 SMC2 RFX5 JMJD1C NCOR1 TCERG1 TLN1 PES1 SMARCC1 NCOA1 MACF1 ZFR EIF2A DDX41 COPS5 TOP1 KIF11 KNL1 | 1.29e-05 | 1245 | 129 | 22 | int:CEBPA |
| Interaction | PHF21A interactions | EHBP1 CASP8AP2 DSP ERC1 BCORL1 JMJD1C ZFHX4 BRCA2 ZBTB11 UTRN KNL1 | 1.32e-05 | 343 | 129 | 11 | int:PHF21A |
| Interaction | SRPK2 interactions | ERC1 ZC3H13 MCM4 RRP8 PRPF40A JMJD1C NKRF PPIG SETD2 ZFHX4 PES1 MACF1 TOP1 RBM34 KIF11 NOL8 | 1.41e-05 | 717 | 129 | 16 | int:SRPK2 |
| Interaction | SOX7 interactions | 1.44e-05 | 82 | 129 | 6 | int:SOX7 | |
| Interaction | DOT1L interactions | ZC3H13 AHCTF1 TMOD3 LAMA5 RRP8 RFC1 SMC2 PRPF40A NKRF NSD3 MDN1 TCERG1 JRK PES1 ZFR RBM34 NOL8 | 1.57e-05 | 807 | 129 | 17 | int:DOT1L |
| Interaction | SUZ12 interactions | ZCWPW2 ZC3H13 AHCTF1 MCM4 SMC2 NKRF TASOR2 USP42 RMDN1 PES1 BRD7 SMARCA1 SMARCC1 TOP1 RBM34 | 1.62e-05 | 644 | 129 | 15 | int:SUZ12 |
| Interaction | HMGA1 interactions | DSP CWC27 AHCTF1 MCM4 MSL1 HMGB1P1 BRCA2 ARHGEF10 TAX1BP1 BRD7 SMARCA1 SMARCC1 | 1.63e-05 | 419 | 129 | 12 | int:HMGA1 |
| Interaction | WWTR1 interactions | ERC1 AHCTF1 SMC2 ERBIN PRPF40A JMJD1C NCOR1 SETD2 TCERG1 TLN1 SMARCC1 AFDN | 1.75e-05 | 422 | 129 | 12 | int:WWTR1 |
| Interaction | YAP1 interactions | TFEB DSP CWC27 ERC1 AHCTF1 SPTBN2 TMOD3 SMC2 ERBIN JMJD1C NKRF NSD3 NCOR1 SETD2 TCERG1 TLN1 SMARCC1 AFDN ZFR BOD1L1 | 2.11e-05 | 1095 | 129 | 20 | int:YAP1 |
| Interaction | SNW1 interactions | ROCK2 METTL3 DSP CWC27 KIF21A CIR1 MSL1 PRPF40A NCOR1 MDN1 TLN1 BRD7 NCOA1 DDX41 TOP1 KIF11 | 2.33e-05 | 747 | 129 | 16 | int:SNW1 |
| Interaction | SP7 interactions | PRPF40A ZBTB14 NCOR1 ZFHX4 TCERG1 BRD7 SMARCC1 NCOA1 ZFR FILIP1L | 2.66e-05 | 304 | 129 | 10 | int:SP7 |
| Interaction | H2AZ1 interactions | MSL1 RFC1 SMC2 JMJD1C BRD7 SMARCA1 SMARCC1 FH PLK4 TOP1 AFF4 | 2.72e-05 | 371 | 129 | 11 | int:H2AZ1 |
| Interaction | CHD3 interactions | ELOA DSP ZC3H13 RFC1 PRPF40A NKRF MDN1 ZFHX4 TCERG1 SMARCA1 SMARCC1 ZFR DDX41 PLK4 TOP1 RBM34 | 2.73e-05 | 757 | 129 | 16 | int:CHD3 |
| Interaction | PPARG interactions | 2.89e-05 | 307 | 129 | 10 | int:PPARG | |
| Interaction | KLF9 interactions | 2.96e-05 | 93 | 129 | 6 | int:KLF9 | |
| Interaction | MAFB interactions | 2.99e-05 | 246 | 129 | 9 | int:MAFB | |
| Interaction | DHX40 interactions | 3.28e-05 | 249 | 129 | 9 | int:DHX40 | |
| Interaction | RAPGEFL1 interactions | 3.36e-05 | 29 | 129 | 4 | int:RAPGEFL1 | |
| Interaction | RPA4 interactions | AHCTF1 TMOD3 PRPF40A NCOR1 SETD2 MDN1 TCERG1 TLN1 AFDN KIF11 KNL1 NOL8 | 3.43e-05 | 452 | 129 | 12 | int:RPA4 |
| Interaction | SMARCC1 interactions | TMOD3 MSL1 SMC2 PRPF40A NSD3 NCOR1 BRD7 SMARCA1 SMARCC1 NCOA1 TOP1 | 3.72e-05 | 384 | 129 | 11 | int:SMARCC1 |
| Interaction | NINL interactions | ELOA CENPE RIBC2 DSP ERC1 SMC2 CEP128 CCDC88C NCOR1 BRCA2 CBY2 KIF11 | 3.90e-05 | 458 | 129 | 12 | int:NINL |
| Interaction | FGFBP1 interactions | 4.20e-05 | 257 | 129 | 9 | int:FGFBP1 | |
| Interaction | CHAF1A interactions | NUSAP1 ELOA MCM4 RFC1 MDN1 TCERG1 SMARCA1 SMARCC1 DDX41 COPS5 | 4.33e-05 | 322 | 129 | 10 | int:CHAF1A |
| Interaction | BRCA1 interactions | RPGRIP1 ELOA BRIP1 TRIO DSP ERC1 PARG MCM4 RFC1 NKRF ZBTB14 MDN1 BRCA2 TLN1 BRD7 SMARCC1 NCOA1 ZFR TOP1 KIF11 KNL1 | 4.34e-05 | 1249 | 129 | 21 | int:BRCA1 |
| Interaction | CIT interactions | TAPT1 DSP ERC1 VPS4A ZC3H13 AHCTF1 SPTBN2 TMOD2 MCM4 RRP8 PRPF40A NKRF BFSP1 TCERG1 PES1 SMARCA1 SMARCC1 MACF1 ZFR BOD1L1 DDX41 TOP1 KIF11 | 4.43e-05 | 1450 | 129 | 23 | int:CIT |
| Interaction | FBXO42 interactions | 4.46e-05 | 259 | 129 | 9 | int:FBXO42 | |
| Interaction | IFI16 interactions | ELOA AHCTF1 TMOD3 MCM4 RRP8 RFC1 PRPF40A NKRF PES1 SMARCA1 SMARCC1 DDX41 TOP1 RBM34 KIF11 | 5.31e-05 | 714 | 129 | 15 | int:IFI16 |
| Interaction | OBSL1 interactions | DSP SPTBN2 LAMA5 RFC1 PRPF40A NKRF TASOR2 MDN1 TLN1 PES1 MACF1 AFDN ZFR DDX41 UTRN TOP1 RBM34 | 6.35e-05 | 902 | 129 | 17 | int:OBSL1 |
| Interaction | GATA4 interactions | NUSAP1 AHCTF1 SMC2 PRPF40A TASOR2 NCOR1 PPIG TCERG1 SMARCA1 SMARCC1 TOP1 | 6.85e-05 | 411 | 129 | 11 | int:GATA4 |
| Interaction | NUP50 interactions | 6.99e-05 | 341 | 129 | 10 | int:NUP50 | |
| Interaction | SRSF1 interactions | TRIM31 CIR1 RRP8 PRPF40A NKRF PPIG TCERG1 BRD7 SMARCC1 ZBTB11 COPS5 TOP1 RBM34 | 7.61e-05 | 570 | 129 | 13 | int:SRSF1 |
| Interaction | FOXO1 interactions | 8.08e-05 | 347 | 129 | 10 | int:FOXO1 | |
| Interaction | NUCKS1 interactions | 8.73e-05 | 220 | 129 | 8 | int:NUCKS1 | |
| Interaction | KPNA1 interactions | 8.88e-05 | 351 | 129 | 10 | int:KPNA1 | |
| Interaction | H1-2 interactions | EHBP1 VPS4A TRIM31 LAMA2 RRP8 MSL1 PRPF40A USF3 BRD7 BOD1L1 UTRN COPS5 PLK4 TOP1 | 9.51e-05 | 666 | 129 | 14 | int:H1-2 |
| Interaction | BRD2 interactions | METTL3 ARHGAP10 RFC1 NSD3 KMT5B PES1 BRD7 SMARCA1 SMARCC1 DDX41 TOP1 | 1.00e-04 | 429 | 129 | 11 | int:BRD2 |
| Interaction | AKAP13 interactions | 1.02e-04 | 116 | 129 | 6 | int:AKAP13 | |
| Interaction | CHD4 interactions | ELOA DSP MCM4 RFC1 SMC2 PRPF40A NKRF MDN1 ZFHX4 BRCA2 PES1 SMARCA1 SMARCC1 ZFR DDX41 TOP1 RBM34 | 1.02e-04 | 938 | 129 | 17 | int:CHD4 |
| Interaction | NIFK interactions | 1.04e-04 | 431 | 129 | 11 | int:NIFK | |
| Interaction | PFN1 interactions | MAP1A TRIO ERC1 ARHGEF12 PPIG R3HCC1L MACF1 AFDN BOD1L1 TOP1 AFF4 KIF11 | 1.07e-04 | 509 | 129 | 12 | int:PFN1 |
| Interaction | NCAPH2 interactions | 1.09e-04 | 169 | 129 | 7 | int:NCAPH2 | |
| Interaction | DHX8 interactions | 1.12e-04 | 292 | 129 | 9 | int:DHX8 | |
| Interaction | HUS1 interactions | 1.12e-04 | 118 | 129 | 6 | int:HUS1 | |
| Interaction | CEBPB interactions | TICRR DSP ERC1 VPS4A AHCTF1 SPTBN2 MCM4 RFC1 SMC2 PRPF40A NCOR1 TCERG1 BRCA2 TLN1 PES1 SMARCC1 ZFR FH EIF2A DDX41 COPS5 TOP1 | 1.19e-04 | 1443 | 129 | 22 | int:CEBPB |
| Interaction | HSPB8 interactions | 1.22e-04 | 172 | 129 | 7 | int:HSPB8 | |
| Interaction | SNRPB interactions | METTL3 CWC27 PRPF40A PPIG SETD2 TCERG1 TLN1 MACF1 ZFR DDX41 COPS5 TOP1 | 1.23e-04 | 517 | 129 | 12 | int:SNRPB |
| Interaction | NXF1 interactions | MAP1A VPS26B AHCTF1 KIF21A MCM4 MSL1 CEP128 RFX5 NKRF TLN1 PES1 BRD7 APOL6 SMARCC1 MACF1 ZFR EIF2A ZBTB11 DDX41 COPS5 NOL8 | 1.24e-04 | 1345 | 129 | 21 | int:NXF1 |
| Interaction | GAPDH interactions | METTL3 ARHGEF28 DSP VPS26B MYH7B TRIM31 LAMC1 RFC1 PRPF40A TLN1 MACF1 COPS5 AFF4 KNL1 | 1.30e-04 | 686 | 129 | 14 | int:GAPDH |
| Interaction | ZCCHC10 interactions | 1.42e-04 | 236 | 129 | 8 | int:ZCCHC10 | |
| Interaction | IL17B interactions | 1.44e-04 | 78 | 129 | 5 | int:IL17B | |
| Interaction | ARHGEF28 interactions | 1.49e-04 | 42 | 129 | 4 | int:ARHGEF28 | |
| Interaction | TLE3 interactions | 1.56e-04 | 376 | 129 | 10 | int:TLE3 | |
| Interaction | CEP152 interactions | 1.56e-04 | 179 | 129 | 7 | int:CEP152 | |
| Cytoband | 6q15 | 9.63e-05 | 31 | 131 | 3 | 6q15 | |
| GeneFamily | Myosin heavy chains | 6.56e-07 | 15 | 87 | 4 | 1098 | |
| GeneFamily | Laminin subunits | 2.29e-05 | 12 | 87 | 3 | 626 | |
| GeneFamily | Tropomodulins | 1.36e-04 | 4 | 87 | 2 | 1140 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.78e-04 | 34 | 87 | 3 | 487 | |
| GeneFamily | EF-hand domain containing|Plakins | 6.29e-04 | 8 | 87 | 2 | 939 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.41e-03 | 46 | 87 | 3 | 622 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 1.79e-03 | 50 | 87 | 3 | 721 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.12e-03 | 53 | 87 | 3 | 532 | |
| GeneFamily | AAA ATPases | 2.12e-03 | 53 | 87 | 3 | 413 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 3.71e-03 | 19 | 87 | 2 | 909 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.96e-03 | 66 | 87 | 3 | 722 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 4.11e-03 | 20 | 87 | 2 | 548 | |
| GeneFamily | PWWP domain containing | 4.97e-03 | 22 | 87 | 2 | 1147 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | NUSAP1 TRIO CENPE TMOD3 MCM4 RFC1 SMC2 PRPF40A BRCA2 ELF4 BOD1L1 ZBTB11 PLK4 TOP1 AFF4 RBM34 KIF11 KNL1 NOL8 BRWD1 | 4.05e-10 | 721 | 129 | 20 | M10237 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ROCK2 EHBP1 TRIO CENPE ERC1 AHCTF1 PARG LAMC1 SETD2 MDN1 BRCA2 ARHGEF10 SMARCA1 NCOA1 MACF1 ZBTB11 TOP1 KIF11 ARAP2 FILIP1L | 7.57e-09 | 856 | 129 | 20 | M4500 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | NUSAP1 CASP8AP2 CENPE ARHGAP10 CWC27 AHCTF1 DYNC2I1 RFC1 SMC2 FAM13B TASOR2 USP8 PPIG TAX1BP1 ZBTB11 KIF11 KNL1 | 2.53e-08 | 656 | 129 | 17 | M18979 |
| Coexpression | HALLMARK_G2M_CHECKPOINT | NUSAP1 CASP8AP2 CENPE SMC2 BRCA2 SMARCC1 PLK4 TOP1 KIF11 KNL1 | 5.97e-08 | 200 | 129 | 10 | M5901 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.81e-07 | 180 | 129 | 9 | M8239 | |
| Coexpression | FISCHER_DREAM_TARGETS | NUSAP1 EHBP1 CASP8AP2 TICRR BRIP1 CENPE CWC27 AHCTF1 MCM4 RFC1 SMC2 ZBTB14 TCERG1 BRCA2 SMARCC1 PLK4 TOP1 KIF11 KNL1 | 2.86e-07 | 969 | 129 | 19 | M149 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | NUSAP1 ELOA BRIP1 CENPE CWC27 ARHGEF12 MCM4 SMC2 CEP128 FAM13B PRPF40A NSD3 SETD2 TAX1BP1 FH PLK4 KIF11 DOP1A | 3.13e-07 | 877 | 129 | 18 | M2241 |
| Coexpression | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C | NUSAP1 TICRR BRIP1 CENPE ZC3H13 MSL1 NSD3 NCOR1 SETD2 MDN1 KMT5B PLK4 KIF11 | 4.06e-07 | 454 | 129 | 13 | M19927 |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | NUSAP1 CASP8AP2 BRIP1 CENPE VPS26B AHCTF1 MCM4 SMC2 CEP128 TCERG1 BRCA2 FH PLK4 KIF11 KNL1 NOL8 | 4.76e-07 | 714 | 129 | 16 | M1744 |
| Coexpression | FUJII_YBX1_TARGETS_DN | 5.28e-07 | 194 | 129 | 9 | M14340 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | NUSAP1 CASP8AP2 TICRR BRIP1 CENPE MCM4 SMC2 BRCA2 SMARCC1 PLK4 KIF11 KNL1 | 7.50e-07 | 402 | 129 | 12 | MM454 |
| Coexpression | HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP | 1.08e-06 | 68 | 129 | 6 | M41108 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | ZNF704 ELOA TICRR BRIP1 CENPE BCORL1 SMC2 CEP128 NKRF ZBTB14 NSD3 BRCA2 ARHGEF10 MACF1 PLK4 TOP1 KNL1 | 1.89e-06 | 892 | 129 | 17 | M18120 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | NUSAP1 MCM4 RFC1 SMC2 MDN1 TCERG1 BRCA2 PIK3C2G SMARCA1 SMARCC1 ZFR DDX41 COPS5 KIF11 | 2.05e-06 | 612 | 129 | 14 | M4772 |
| Coexpression | EGUCHI_CELL_CYCLE_RB1_TARGETS | 3.82e-06 | 22 | 129 | 4 | M4455 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 4.74e-06 | 323 | 129 | 10 | M9150 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | NUSAP1 CASP8AP2 TICRR BRIP1 CENPE AHCTF1 LAMC1 MCM4 MSL1 RFC1 SMC2 PRPF40A NSD3 BRCA2 ARHGEF10 ZFR PLK4 RBM34 KIF11 KNL1 NOL8 | 5.15e-06 | 1407 | 129 | 21 | M14427 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | NUSAP1 EHBP1 CASP8AP2 CENPE RIBC2 VPS26B CWC27 VPS4A MCM4 RFC1 SMC2 CEP128 BRCA2 RMDN1 BRD7 ELF4 FH PLK4 KIF11 KNL1 FILIP1L | 6.13e-06 | 1423 | 129 | 21 | M45722 |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_UP | 6.19e-06 | 197 | 129 | 8 | M8752 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 6.67e-06 | 199 | 129 | 8 | M5893 | |
| Coexpression | GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP | 6.67e-06 | 199 | 129 | 8 | M3677 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | AHCTF1 CIR1 RFC1 JMJD1C TMCC3 USP42 BRD7 NCOA1 ZFR BOD1L1 ZBTB11 TOP1 AFF4 BRWD1 | 6.86e-06 | 680 | 129 | 14 | M41089 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | NUSAP1 EHBP1 TICRR BRIP1 CENPE MCM4 RFC1 SMC2 BRCA2 SMARCA1 SMARCC1 PLK4 KIF11 KNL1 | 6.86e-06 | 680 | 129 | 14 | MM456 |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP | 6.92e-06 | 200 | 129 | 8 | M7256 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 1.21e-05 | 155 | 129 | 7 | M39041 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 1.62e-05 | 295 | 129 | 9 | M39121 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 1.67e-05 | 163 | 129 | 7 | M8235 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL | 1.85e-05 | 300 | 129 | 9 | M45675 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL | 2.03e-05 | 232 | 129 | 8 | M45800 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_2 | 2.05e-05 | 33 | 129 | 4 | M17333 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 2.36e-05 | 237 | 129 | 8 | M15606 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | CENPE PARG TRIM31 MCM4 SMC2 RFX5 PPIG TCERG1 BRCA2 SMARCC1 PLK4 TOP1 RBM34 KIF11 | 2.40e-05 | 761 | 129 | 14 | M11961 |
| Coexpression | BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP | 2.48e-05 | 12 | 129 | 3 | M34000 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 2.59e-05 | 240 | 129 | 8 | MM976 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_TCONV_DN | 3.17e-05 | 180 | 129 | 7 | M2961 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | 3.29e-05 | 323 | 129 | 9 | M2156 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | NUSAP1 CASP8AP2 TRIO LAMA5 LAMC1 MCM4 MSL1 JMJD1C NCOR1 FRY TCERG1 RMDN1 MACF1 COPS5 | 3.61e-05 | 790 | 129 | 14 | M12490 |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN | 4.04e-05 | 187 | 129 | 7 | M34027 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 4.04e-05 | 187 | 129 | 7 | M2984 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN | 4.32e-05 | 189 | 129 | 7 | M8275 | |
| Coexpression | KAMMINGA_EZH2_TARGETS | 4.92e-05 | 41 | 129 | 4 | M1486 | |
| Coexpression | VEGF_A_UP.V1_DN | 4.93e-05 | 193 | 129 | 7 | M2675 | |
| Coexpression | KAMMINGA_EZH2_TARGETS | 5.42e-05 | 42 | 129 | 4 | MM1159 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN | 5.99e-05 | 199 | 129 | 7 | M5382 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP | 5.99e-05 | 199 | 129 | 7 | M5607 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 6.18e-05 | 200 | 129 | 7 | M5041 | |
| Coexpression | GSE14308_TH17_VS_INDUCED_TREG_UP | 6.18e-05 | 200 | 129 | 7 | M3385 | |
| Coexpression | GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN | 6.18e-05 | 200 | 129 | 7 | M8069 | |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | 6.18e-05 | 200 | 129 | 7 | M387 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN | 6.18e-05 | 200 | 129 | 7 | M8997 | |
| Coexpression | GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN | 6.18e-05 | 200 | 129 | 7 | M7502 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP | 6.18e-05 | 200 | 129 | 7 | M7500 | |
| Coexpression | GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_DN | 6.18e-05 | 200 | 129 | 7 | M3074 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | NUSAP1 CASP8AP2 TICRR BRIP1 MCM4 RFC1 SMC2 PRPF40A NSD3 BRCA2 BRD7 SMARCC1 FH EIF2A COPS5 PLK4 KIF11 KNL1 | 6.28e-05 | 1290 | 129 | 18 | M80 |
| Coexpression | WANG_LMO4_TARGETS_DN | 7.75e-05 | 361 | 129 | 9 | M12674 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 8.90e-05 | 212 | 129 | 7 | M39221 | |
| Coexpression | ACEVEDO_LIVER_CANCER_UP | ROCK2 NUSAP1 METTL3 CWC27 AHCTF1 MCM4 RFX5 HMGB1P1 USP8 RMDN1 SMARCA1 SMARCC1 ZFR AFF4 RBM34 | 9.00e-05 | 972 | 129 | 15 | M15709 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.07e-04 | 466 | 129 | 10 | M13522 | |
| Coexpression | CROONQUIST_IL6_DEPRIVATION_DN | 1.09e-04 | 95 | 129 | 5 | M18506 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | ZNF704 METTL3 ARHGAP10 ZC3H13 DYNC2I1 ZBTB14 NCOR1 TAX1BP1 ZBTB11 NOL8 | 1.09e-04 | 467 | 129 | 10 | M1347 |
| Coexpression | KIM_WT1_TARGETS_DN | NUSAP1 METTL3 CENPE PARG PRPF40A PPIG RMDN1 COPS5 KIF11 BRWD1 | 1.17e-04 | 471 | 129 | 10 | M17859 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | NUSAP1 TICRR BRIP1 CENPE MCM4 CEP128 BFSP1 BRCA2 PLK4 KIF11 KNL1 | 1.17e-04 | 567 | 129 | 11 | M45692 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | 1.32e-04 | 478 | 129 | 10 | M45785 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | ZNF704 METTL3 ARHGAP10 ZC3H13 DYNC2I1 ZBTB14 NCOR1 TAX1BP1 ZBTB11 NOL8 | 1.46e-04 | 484 | 129 | 10 | MM999 |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 1.65e-04 | 164 | 129 | 6 | M19957 | |
| Coexpression | TANG_SENESCENCE_TP53_TARGETS_DN | 1.69e-04 | 56 | 129 | 4 | M6171 | |
| Coexpression | GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP | 1.82e-04 | 167 | 129 | 6 | M365 | |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 1.88e-04 | 168 | 129 | 6 | M18811 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 1.92e-04 | 240 | 129 | 7 | M39236 | |
| Coexpression | LE_EGR2_TARGETS_UP | 2.07e-04 | 109 | 129 | 5 | MM1148 | |
| Coexpression | LE_EGR2_TARGETS_UP | 2.16e-04 | 110 | 129 | 5 | M12804 | |
| Coexpression | LEE_EARLY_T_LYMPHOCYTE_UP | 2.26e-04 | 111 | 129 | 5 | M7357 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_DN | 2.28e-04 | 174 | 129 | 6 | M2996 | |
| Coexpression | GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_UP | 2.81e-04 | 181 | 129 | 6 | M2994 | |
| Coexpression | GCNP_SHH_UP_LATE.V1_UP | 2.81e-04 | 181 | 129 | 6 | M2641 | |
| Coexpression | WHITEFORD_PEDIATRIC_CANCER_MARKERS | 2.88e-04 | 117 | 129 | 5 | M7854 | |
| Coexpression | PUJANA_BRCA_CENTERED_NETWORK | 3.00e-04 | 118 | 129 | 5 | M15305 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 3.07e-04 | 434 | 129 | 9 | M15150 | |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 3.12e-04 | 27 | 129 | 3 | M2483 | |
| Coexpression | GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN | 3.16e-04 | 185 | 129 | 6 | M2965 | |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 3.49e-04 | 28 | 129 | 3 | MM1323 | |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 3.65e-04 | 190 | 129 | 6 | M761 | |
| Coexpression | BENPORATH_CYCLING_GENES | NUSAP1 CASP8AP2 CENPE DSP MCM4 JMJD1C KMT5B BRD7 AFDN TOP1 KIF11 | 3.70e-04 | 648 | 129 | 11 | M8156 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RFX5 FAM13B ERBIN PRPF40A JMJD1C CCDC88C NCOR1 PPIG SETD2 USP42 TLN1 NCOA1 MACF1 ZFR BOD1L1 UTRN ARAP2 BRWD1 | 3.80e-04 | 1492 | 129 | 18 | M40023 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 3.86e-04 | 448 | 129 | 9 | MM1044 | |
| Coexpression | CROONQUIST_NRAS_SIGNALING_DN | 3.99e-04 | 70 | 129 | 4 | M10739 | |
| Coexpression | SENESE_HDAC1_TARGETS_UP | 4.05e-04 | 451 | 129 | 9 | M14973 | |
| Coexpression | WHITFIELD_CELL_CYCLE_M_G1 | 4.05e-04 | 126 | 129 | 5 | M2078 | |
| Coexpression | GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP | 4.07e-04 | 194 | 129 | 6 | M8017 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 4.07e-04 | 194 | 129 | 6 | M7306 | |
| Coexpression | GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN | 4.07e-04 | 194 | 129 | 6 | M4912 | |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 4.18e-04 | 195 | 129 | 6 | M13736 | |
| Coexpression | VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP | 4.20e-04 | 127 | 129 | 5 | M40952 | |
| Coexpression | ERBB2_UP.V1_DN | 4.42e-04 | 197 | 129 | 6 | M2635 | |
| Coexpression | GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN | 4.42e-04 | 197 | 129 | 6 | M6835 | |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | 4.53e-04 | 458 | 129 | 9 | M8520 | |
| Coexpression | GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN | 4.54e-04 | 198 | 129 | 6 | M7605 | |
| Coexpression | GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN | 4.54e-04 | 198 | 129 | 6 | M8355 | |
| Coexpression | GSE12366_GC_VS_NAIVE_BCELL_UP | 4.54e-04 | 198 | 129 | 6 | M3168 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 4.54e-04 | 198 | 129 | 6 | M4451 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ROCK2 NUSAP1 CASP8AP2 TICRR CENPE ZC3H13 AHCTF1 KIF21A DYNC2I1 MCM4 RFC1 SMC2 CEP128 PRPF40A NKRF CCDC88C PPIG MDN1 TCERG1 BRCA2 USP42 TAX1BP1 BRD7 SMARCC1 MACF1 BOD1L1 FH PLK4 TOP1 KIF11 KNL1 NOL8 BRWD1 | 3.70e-13 | 1257 | 128 | 33 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | ROCK2 NUSAP1 TICRR CENPE CIR1 DYNC2I1 SMC2 PRPF40A NKRF PPIG ZFHX4 BRCA2 TAX1BP1 BRD7 MACF1 BOD1L1 TOP1 KNL1 FILIP1L BRWD1 | 1.52e-12 | 432 | 128 | 20 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ROCK2 NUSAP1 CASP8AP2 TICRR CENPE ZC3H13 AHCTF1 KIF21A DYNC2I1 MCM4 RFC1 SMC2 CEP128 PRPF40A NKRF CCDC88C PPIG MDN1 TCERG1 BRCA2 USP42 TAX1BP1 BRD7 SMARCC1 MACF1 BOD1L1 FH PLK4 TOP1 KIF11 KNL1 NOL8 BRWD1 | 2.12e-11 | 1459 | 128 | 33 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | ROCK2 NUSAP1 ZNF704 TFEB TICRR VAX1 CENPE KIF21A CIR1 ARHGEF12 DYNC2I1 SMC2 PRPF40A NKRF PPIG ZFHX4 BRCA2 TAX1BP1 BRD7 MACF1 BOD1L1 TOP1 ARAP2 JHY KNL1 FILIP1L BRWD1 | 3.21e-11 | 989 | 128 | 27 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | ARHGAP42 ROCK2 NUSAP1 CASP8AP2 TICRR METTL3 CENPE MYH7B AHCTF1 DYNC2I1 SMC2 ERBIN PRPF40A NKRF PPIG MDN1 BRCA2 BRD7 SMARCC1 MACF1 BOD1L1 FH RNF207 PLK4 TOP1 RBM34 KNL1 NOL8 FILIP1L BRWD1 | 4.25e-11 | 1241 | 128 | 30 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ARHGAP42 ROCK2 NUSAP1 CASP8AP2 TICRR CENPE ERC1 VPS4A AHCTF1 KIF21A TMOD2 DYNC2I1 RFC1 SMC2 CEP128 PRPF40A NKRF NSD3 PPIG R3HCC1L MDN1 BRCA2 TAX1BP1 BRD7 SMARCC1 BOD1L1 PLK4 TOP1 KNL1 FILIP1L | 5.28e-11 | 1252 | 128 | 30 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ROCK2 CASP8AP2 CENPE AHCTF1 KIF21A PARG BCORL1 SMC2 PRPF40A NKRF TCERG1 BRCA2 BRD7 SMARCC1 PLK4 TOP1 KIF11 JHY NOL8 | 4.83e-10 | 532 | 128 | 19 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | NUSAP1 CASP8AP2 TICRR MAP1A CENPE ERC1 ZC3H13 KIF21A TMOD2 DYNC2I1 SMC2 CEP128 PRPF40A CCDC88C PPIG BRCA2 SMARCC1 MACF1 BOD1L1 RNF207 PLK4 TOP1 KIF11 KNL1 NOL8 BRWD1 | 7.91e-10 | 1060 | 128 | 26 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | ARHGAP42 ROCK2 NUSAP1 CASP8AP2 TICRR METTL3 CENPE MYH7B AHCTF1 DYNC2I1 SMC2 ERBIN PRPF40A NKRF PPIG MDN1 BRCA2 BRD7 SMARCC1 MACF1 BOD1L1 FH RNF207 PLK4 TOP1 RBM34 KNL1 NOL8 FILIP1L BRWD1 | 2.37e-09 | 1468 | 128 | 30 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | ROCK2 NUSAP1 CENPE PARG BCORL1 CIR1 SMC2 PRPF40A NKRF TCERG1 BRCA2 BRD7 SMARCC1 PLK4 TOP1 JHY NOL8 | 3.44e-09 | 469 | 128 | 17 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ROCK2 NUSAP1 CENPE KIF21A CIR1 ARHGEF12 DYNC2I1 SMC2 PRPF40A NKRF PPIG BRCA2 USP42 TAX1BP1 BRD7 MACF1 BOD1L1 TOP1 KNL1 | 7.55e-09 | 629 | 128 | 19 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | ELOA TICRR CENPE DYNC2I1 SMC2 PPIG USF3 BRCA2 CBY2 MACF1 TOP1 AFF4 FILIP1L | 2.39e-08 | 291 | 128 | 13 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | ELOA TICRR CENPE ERC1 VPS4A KIF21A ARHGEF12 DYNC2I1 SMC2 ERBIN PPIG SETD2 USF3 R3HCC1L BRCA2 CBY2 SMARCA1 MACF1 TOP1 AFF4 | 4.49e-08 | 780 | 128 | 20 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ROCK2 NUSAP1 CASP8AP2 CENPE NKRF NCOR1 PPIG USF3 TCERG1 BRCA2 BOD1L1 TOP1 KNL1 | 5.21e-08 | 311 | 128 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | ROCK2 NUSAP1 CASP8AP2 MAP1A CENPE KIF21A NKRF CCDC88C NCOR1 PPIG SETD2 USF3 TCERG1 BRCA2 CBY2 BOD1L1 MAPK10 TOP1 JHY KNL1 NOL8 BRWD1 | 1.08e-07 | 989 | 128 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | NUSAP1 CASP8AP2 CENPE DYNC2I1 SMC2 BRCA2 MACF1 BOD1L1 TOP1 KNL1 | 1.94e-07 | 186 | 128 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | NUSAP1 CASP8AP2 TICRR MAP1A CENPE ERC1 ZC3H13 KIF21A TMOD2 DYNC2I1 SMC2 CEP128 PRPF40A CCDC88C PPIG BRCA2 SMARCC1 MACF1 BOD1L1 RNF207 PLK4 TOP1 KIF11 KNL1 NOL8 BRWD1 | 2.75e-07 | 1414 | 128 | 26 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | ROCK2 TFEB TICRR VAX1 CENPE DYNC2I1 SMC2 PRPF40A NKRF PPIG ZFHX4 BRCA2 TOP1 ARAP2 FILIP1L | 2.89e-07 | 492 | 128 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | ROCK2 TICRR CENPE DYNC2I1 SMC2 PRPF40A NKRF PPIG BRCA2 TOP1 FILIP1L | 4.26e-07 | 255 | 128 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | ZNF704 ELOA TICRR CENPE ERC1 KIF21A LAMA2 ARHGEF12 DYNC2I1 SMC2 PPIG USF3 ZFHX4 BRCA2 CBY2 MACF1 FH UTRN TOP1 AFF4 FILIP1L | 4.37e-07 | 985 | 128 | 21 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | NUSAP1 CASP8AP2 TICRR CENPE KIF21A TMOD2 MCM4 RRP8 RFC1 SMC2 PRPF40A NKRF CCDC88C PPIG MDN1 TCERG1 BRCA2 BRD7 SMARCA1 SMARCC1 EIF2A TOP1 KIF11 KNL1 NOL8 | 5.68e-07 | 1371 | 128 | 25 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ROCK2 NUSAP1 CASP8AP2 ELOA CENPE ERC1 KIF21A NKRF NCOR1 PPIG SETD2 R3HCC1L TCERG1 BRCA2 BOD1L1 TOP1 AFF4 KNL1 NOL8 | 5.84e-07 | 831 | 128 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | ZNF704 CENPE KIF21A LAMA2 ARHGEF12 DYNC2I1 SMC2 PPIG ZFHX4 BRCA2 MACF1 UTRN TOP1 FILIP1L | 1.67e-06 | 492 | 128 | 14 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | ROCK2 NUSAP1 CASP8AP2 MAP1A CENPE KIF21A CCDC88C TCERG1 BRCA2 MAPK10 TOP1 JHY KNL1 NOL8 | 1.92e-06 | 498 | 128 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | NUSAP1 CENPE DYNC2I1 PRPF40A NKRF BRCA2 TOP1 ARAP2 DOP1A FILIP1L | 2.49e-06 | 246 | 128 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.53e-06 | 192 | 128 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 2.53e-06 | 192 | 128 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 4.16e-06 | 204 | 128 | 9 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | NUSAP1 CASP8AP2 TICRR MAP1A CENPE ZC3H13 KIF21A SPTBN2 TMOD2 DYNC2I1 RFC1 SMC2 RFX5 CCDC88C PPIG BRCA2 ZFR BOD1L1 PLK4 TOP1 KIF11 KNL1 BRWD1 | 6.88e-06 | 1370 | 128 | 23 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | NUSAP1 TRIO ZC3H13 CIR1 CEP128 JMJD1C PPIG USP42 TAX1BP1 MACF1 ZBTB11 UTRN KNL1 BRWD1 | 8.02e-06 | 564 | 128 | 14 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | NUSAP1 CASP8AP2 VAX1 MAP1A CENPE KIF21A DYNC2I1 NKRF CCDC88C BRCA2 MAPK10 TOP1 NOL8 | 9.08e-06 | 493 | 128 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.17e-05 | 232 | 128 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | NUSAP1 TICRR CENPE PRPF40A PPIG BRCA2 CBY2 MACF1 TOP1 FILIP1L | 1.34e-05 | 298 | 128 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | NUSAP1 CASP8AP2 CENPE MYH7B ZC3H13 MCM4 RFC1 SMC2 NKRF CCDC88C PPIG MDN1 TCERG1 BRCA2 SMARCC1 EIF2A PLK4 TOP1 KIF11 NOL8 | 2.14e-05 | 1164 | 128 | 20 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | NUSAP1 CASP8AP2 VAX1 MAP1A CENPE KIF21A DYNC2I1 PRPF40A NKRF CCDC88C MDN1 BRCA2 MAPK10 TOP1 ARAP2 DOP1A NOL8 FILIP1L | 2.52e-05 | 983 | 128 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | NUSAP1 ZNF704 TICRR BRIP1 TAPT1 CENPE SMC2 CEP128 BRCA2 KIF11 KNL1 | 3.06e-05 | 399 | 128 | 11 | GSM538345_500 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | NUSAP1 TICRR BRIP1 CENPE MCM4 SMC2 CEP128 BRCA2 PLK4 KIF11 KNL1 | 3.83e-05 | 409 | 128 | 11 | GSM399452_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | NUSAP1 TICRR BRIP1 CENPE LAMC1 MCM4 SMC2 BRCA2 PLK4 KIF11 KNL1 | 3.92e-05 | 410 | 128 | 11 | GSM538387_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | NUSAP1 TICRR BRIP1 CENPE DSP MCM4 SMC2 MAPK10 PLK4 KIF11 KNL1 | 4.77e-05 | 419 | 128 | 11 | GSM476664_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3 | NUSAP1 TICRR BRIP1 TRIO CENPE SMC2 SMARCC1 UTRN AFF4 KIF11 KNL1 | 5.20e-05 | 423 | 128 | 11 | GSM476655_500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | NUSAP1 CASP8AP2 CENPE MYH7B ZC3H13 LAMA5 MCM4 RFC1 SMC2 NKRF CCDC88C PPIG MDN1 TCERG1 BRCA2 SMARCC1 EIF2A PLK4 TOP1 KIF11 NOL8 | 5.42e-05 | 1347 | 128 | 21 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | alpha beta T cells, T.8.TI.B16, 4- 8+ TCR+ 45+, B16 Melanoma Tumor, avg-2 | 6.53e-05 | 359 | 128 | 10 | GSM605773_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 1.07e-04 | 124 | 128 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | 1.24e-04 | 388 | 128 | 10 | GSM538352_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | 1.49e-04 | 397 | 128 | 10 | GSM791143_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | 1.52e-04 | 398 | 128 | 10 | GSM538338_500 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 1.52e-04 | 398 | 128 | 10 | GSM399397_500 | |
| CoexpressionAtlas | Stem Cells, SC.MDP.BM, Sca1- Flt3+ MCSFR+ cKithi, Bone marrow, avg-3 | 1.65e-04 | 402 | 128 | 10 | GSM791105_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 1.65e-04 | 402 | 128 | 10 | GSM605898_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | NUSAP1 CASP8AP2 CENPE DYNC2I1 SMC2 BRCA2 MACF1 BOD1L1 TOP1 KNL1 FILIP1L | 1.97e-04 | 492 | 128 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 2.15e-04 | 90 | 128 | 5 | GSM399403_100 | |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 2.22e-04 | 417 | 128 | 10 | GSM399403_500 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | 2.30e-04 | 419 | 128 | 10 | GSM538348_500 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | 2.44e-04 | 422 | 128 | 10 | GSM538355_500 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | TFEB CWC27 MYH7B KIF21A SPTBN2 MCM4 RFC1 ZNF235 TMCC3 CCDC88C MDN1 TCERG1 BRCA2 PES1 AFDN RNF207 PLK4 KIF11 | 2.75e-04 | 1187 | 128 | 18 | facebase_RNAseq_e9.5_OlfPlac_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | ROCK2 NUSAP1 CASP8AP2 VAX1 MAP1A CENPE KIF21A ZNF235 CCDC88C BRCA2 NCOA1 MACF1 MAPK10 PLK4 TOP1 JHY | 2.93e-04 | 986 | 128 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.09e-04 | 281 | 128 | 8 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.36e-04 | 225 | 128 | 7 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 4.53e-04 | 162 | 128 | 6 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.98e-04 | 230 | 128 | 7 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | 5.03e-04 | 380 | 128 | 9 | GSM538207_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.15e-04 | 166 | 128 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K1 | |
| CoexpressionAtlas | alpha beta T cells, NKT.44+NK1.1-.Th, aGC CD1d tet CD3 CD44, Thymus, avg-3 | 6.28e-04 | 392 | 128 | 9 | GSM538335_500 | |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | 6.63e-04 | 395 | 128 | 9 | GSM538340_500 | |
| CoexpressionAtlas | Stem Cells, SC.CDP.BM, Sca1- Flt3+ MCSFR+ cKitlo, Bone marrow, avg-3 | 7.38e-04 | 401 | 128 | 9 | GSM791114_500 | |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2 | 7.38e-04 | 401 | 128 | 9 | GSM399450_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.75e-04 | 323 | 128 | 8 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | NUSAP1 TICRR VAX1 CENPE PRPF40A PPIG BRCA2 CBY2 NCOA1 MACF1 MAPK10 TOP1 JHY NOL8 FILIP1L | 8.26e-04 | 979 | 128 | 15 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2 | 8.39e-04 | 327 | 128 | 8 | GSM538380_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.96e-04 | 71 | 128 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.01e-04 | 123 | 128 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3 | 9.24e-04 | 414 | 128 | 9 | GSM476660_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | NUSAP1 TRIO VPS26B KIF21A CIR1 ARHGEF12 PPIG USP42 TAX1BP1 MACF1 BOD1L1 | 9.63e-04 | 595 | 128 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | TRIO ZC3H13 BCORL1 RFC1 SMC2 JMJD1C NSD3 TLN1 SMARCC1 ZFR UTRN TOP1 KNL1 | 9.81e-04 | 790 | 128 | 13 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | 9.88e-04 | 418 | 128 | 9 | GSM538350_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN2B.Th, Lin-/lo CD25hi CD44+ cKitint, Thymus, avg-2 | 1.02e-03 | 420 | 128 | 9 | GSM791141_500 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, AA4.1+ CD117+ IL7R+ CD45R- CD24- CD19- IgM-, Bone marrow, avg-1 | 1.04e-03 | 338 | 128 | 8 | GSM538347_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | 1.06e-03 | 422 | 128 | 9 | GSM476658_500 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | 1.06e-03 | 422 | 128 | 9 | GSM538357_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.06e-03 | 339 | 128 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.12e-03 | 129 | 128 | 5 | gudmap_developingKidney_e14.5 whole kidney - wildtype_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_500 | 1.24e-03 | 132 | 128 | 5 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | CENPE LAMC1 RRP8 RFC1 SMC2 PRPF40A NCOR1 ZFHX4 SMARCA1 SMARCC1 TBX20 UTRN KIF11 | 1.24e-03 | 811 | 128 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_100 | 1.26e-03 | 9 | 128 | 2 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_100_k3 | |
| CoexpressionAtlas | B cells, B.Fo.PC, IgD+ IgM+ CD19+ CD43- CD5- CD23+, Peritoneal Cavity, avg-3 | 1.34e-03 | 352 | 128 | 8 | GSM538198_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CASP8AP2 TICRR BRIP1 DSP PARG ZNF235 NKRF TASOR2 MDN1 BRCA2 DOP1A NOL8 BRWD1 | 1.37e-03 | 820 | 128 | 13 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.41e-03 | 275 | 128 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.46e-03 | 203 | 128 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.51e-03 | 138 | 128 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.70e-03 | 284 | 128 | 7 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.74e-03 | 210 | 128 | 6 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | 1.75e-03 | 85 | 128 | 4 | GSM476664_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | TICRR CENPE LAMA2 DYNC2I1 PRPF40A PPIG ZFHX4 BRCA2 MACF1 TOP1 DOP1A FILIP1L | 1.82e-03 | 744 | 128 | 12 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#2 | 1.87e-03 | 145 | 128 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K2 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 1.96e-03 | 374 | 128 | 8 | GSM538389_500 | |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 1.99e-03 | 88 | 128 | 4 | GSM399452_100 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | 1.99e-03 | 88 | 128 | 4 | GSM538357_100 | |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-1 | 2.03e-03 | 376 | 128 | 8 | GSM538418_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3 | 2.07e-03 | 89 | 128 | 4 | GSM476660_100 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | 2.07e-03 | 89 | 128 | 4 | GSM538355_100 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ROCK2 PARG ERBIN JMJD1C NCOR1 USP8 SETD2 TLN1 SMARCC1 MACF1 UTRN FILIP1L | 2.89e-13 | 184 | 130 | 12 | 1154a5ad7b8512272b7476f949ddac350910bfb7 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | NUSAP1 TICRR BRIP1 CENPE SMC2 CEP128 BRCA2 PIK3C2G PLK4 KIF11 KNL1 | 8.99e-12 | 187 | 130 | 11 | 057569c9437219ecc396aa6e673b1178a2273837 |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | NUSAP1 TICRR BRIP1 CENPE RIBC2 KIF21A SMC2 BRCA2 PLK4 KIF11 KNL1 | 1.07e-11 | 190 | 130 | 11 | 005967c540418b85311308072a07c684f4296aef |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | ARHGAP42 NUSAP1 TICRR CENPE LAMC1 MCM4 SMC2 CEP128 PLK4 KIF11 KNL1 | 1.34e-11 | 194 | 130 | 11 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | NUSAP1 TICRR BRIP1 CENPE MCM4 SMC2 CEP128 BRCA2 PLK4 KIF11 KNL1 | 1.50e-11 | 196 | 130 | 11 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | NUSAP1 TICRR BRIP1 CENPE RIBC2 SMC2 CEP128 BRCA2 PLK4 KIF11 KNL1 | 1.50e-11 | 196 | 130 | 11 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | NUSAP1 TICRR BRIP1 CENPE MCM4 SMC2 CEP128 BRCA2 PLK4 KIF11 KNL1 | 1.58e-11 | 197 | 130 | 11 | 8b616cde333bdbc0c591035ad9e4949155866245 |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | NUSAP1 ZNF704 TICRR BRIP1 CENPE MCM4 SMC2 BRCA2 PLK4 KIF11 KNL1 | 1.58e-11 | 197 | 130 | 11 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | ROCK2 ZC3H13 RFC1 NSD3 NCOR1 PPIG BRD7 APOL6 BOD1L1 UTRN BRWD1 | 1.76e-11 | 199 | 130 | 11 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | NUSAP1 TICRR BRIP1 CENPE MCM4 SMC2 CEP128 BRCA2 PLK4 KIF11 KNL1 | 1.86e-11 | 200 | 130 | 11 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-T/NK_proliferative|Int-URO / Disease, condition lineage and cell class | NUSAP1 TICRR BRIP1 CENPE RIBC2 KIF21A MCM4 SMC2 BRCA2 PLK4 KIF11 | 1.86e-11 | 200 | 130 | 11 | 99acc1ea01288efdd5b166aa20d66735f2bbe543 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-10 | 174 | 130 | 10 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-10 | 175 | 130 | 10 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | NUSAP1 CASP8AP2 TICRR BRIP1 MCM4 CEP128 BRCA2 PLK4 KIF11 KNL1 | 1.36e-10 | 179 | 130 | 10 | 88d44b04eb5c079531db663ed98ddb20b60feb9a |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-10 | 180 | 130 | 10 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 1.60e-10 | 182 | 130 | 10 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | NUSAP1 TICRR BRIP1 CENPE SMC2 BRCA2 SERPINA9 PLK4 KIF11 KNL1 | 1.88e-10 | 185 | 130 | 10 | 9766216b41ee62bbac4caa25cb98ec5627a24075 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | ARHGAP42 ROCK2 CASP8AP2 ZC3H13 ARHGEF12 ERBIN PRPF40A USP8 PPIG BOD1L1 | 1.98e-10 | 186 | 130 | 10 | 03db813598b67b1e08f759758a1c2023396921fa |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.20e-10 | 188 | 130 | 10 | 6c05797a5d0635d89ffcf4aca52178687129ccb4 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.57e-10 | 191 | 130 | 10 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-10 | 191 | 130 | 10 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.85e-10 | 193 | 130 | 10 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-10 | 194 | 130 | 10 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 2.99e-10 | 194 | 130 | 10 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.99e-10 | 194 | 130 | 10 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-10 | 194 | 130 | 10 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | control-Lymphocytic-Prol._cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.99e-10 | 194 | 130 | 10 | 4c76508de3291c952386caffda2d559629ba5998 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.99e-10 | 194 | 130 | 10 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | NUSAP1 CASP8AP2 TICRR BRIP1 RIBC2 MCM4 SMC2 CEP128 BRCA2 PLK4 | 3.15e-10 | 195 | 130 | 10 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 3.15e-10 | 195 | 130 | 10 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.15e-10 | 195 | 130 | 10 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.15e-10 | 195 | 130 | 10 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | NUSAP1 CASP8AP2 TICRR BRIP1 RIBC2 MCM4 SMC2 CEP128 BRCA2 PLK4 | 3.31e-10 | 196 | 130 | 10 | df366d76ea55f49e349d622effa57c1535df8400 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.31e-10 | 196 | 130 | 10 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | control-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.31e-10 | 196 | 130 | 10 | 886f7c865b086d6ebb4a1746865c30af6bbed345 | |
| ToppCell | Healthy-T/NK_proliferative|Healthy / disease group, cell group and cell class | 3.31e-10 | 196 | 130 | 10 | 91e44aabb2e85dcc77ddae6f7e000118d45d1de6 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 3.31e-10 | 196 | 130 | 10 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.48e-10 | 197 | 130 | 10 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.48e-10 | 197 | 130 | 10 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Healthy-T/NK_proliferative|World / disease group, cell group and cell class | 3.48e-10 | 197 | 130 | 10 | e90be1e7e02f736b6aab14010a912b592d6f1e80 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.48e-10 | 197 | 130 | 10 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.48e-10 | 197 | 130 | 10 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 3.65e-10 | 198 | 130 | 10 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 3.65e-10 | 198 | 130 | 10 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 3.65e-10 | 198 | 130 | 10 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 3.84e-10 | 199 | 130 | 10 | d44cc74d7171d96add61dae821daf774b17d4c69 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 3.84e-10 | 199 | 130 | 10 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | Healthy_donor-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 3.84e-10 | 199 | 130 | 10 | 1311dfd74b991f48b047a439f04f9bf7dfaa0e7a | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 3.84e-10 | 199 | 130 | 10 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.84e-10 | 199 | 130 | 10 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.03e-10 | 200 | 130 | 10 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.03e-10 | 200 | 130 | 10 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.03e-10 | 200 | 130 | 10 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.03e-10 | 200 | 130 | 10 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-09 | 169 | 130 | 9 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-09 | 174 | 130 | 9 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-09 | 180 | 130 | 9 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-09 | 182 | 130 | 9 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.44e-09 | 182 | 130 | 9 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 3.61e-09 | 183 | 130 | 9 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-09 | 187 | 130 | 9 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-09 | 187 | 130 | 9 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-09 | 187 | 130 | 9 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.78e-09 | 189 | 130 | 9 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.01e-09 | 190 | 130 | 9 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.01e-09 | 190 | 130 | 9 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 5.01e-09 | 190 | 130 | 9 | 451eaceb0cb0ec6cfcae00253c0e5c92a168c2f3 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-09 | 191 | 130 | 9 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-09 | 191 | 130 | 9 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-09 | 191 | 130 | 9 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.49e-09 | 192 | 130 | 9 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Cycling_T|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.74e-09 | 193 | 130 | 9 | 81e6240cffb094b2aa3684fd0889b6497f47c4f0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.74e-09 | 193 | 130 | 9 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.01e-09 | 194 | 130 | 9 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.01e-09 | 194 | 130 | 9 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.01e-09 | 194 | 130 | 9 | 3c385d93c5fe1a7817813c492f79fdb94d887357 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.01e-09 | 194 | 130 | 9 | 635d0e88f9c542a1d9363066c6cdbc6e44db76c1 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.01e-09 | 194 | 130 | 9 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.28e-09 | 195 | 130 | 9 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.28e-09 | 195 | 130 | 9 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.28e-09 | 195 | 130 | 9 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 6.28e-09 | 195 | 130 | 9 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.28e-09 | 195 | 130 | 9 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 6.28e-09 | 195 | 130 | 9 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.28e-09 | 195 | 130 | 9 | 75759fd7f925725f0ecd07214afcca5aa2158f9e | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.57e-09 | 196 | 130 | 9 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.57e-09 | 196 | 130 | 9 | f70a2b227716a0df3c1aa6a414b822e63f209a43 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 6.57e-09 | 196 | 130 | 9 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 6.87e-09 | 197 | 130 | 9 | 189d97a6c2ff8803db8cc05e205c9d88dac3911f | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-SEP / Disease, Lineage and Cell Type | 6.87e-09 | 197 | 130 | 9 | 908e91fa16134b61943aea5e8fc0d6fbac8a8c6e | |
| ToppCell | Healthy/Control-T/NK_proliferative|World / Disease group and Cell class | 6.87e-09 | 197 | 130 | 9 | 4a4d3083938783d6f5b87da02f10e501917da0b4 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class | 6.87e-09 | 197 | 130 | 9 | 718a84e9a8248080f2d964e7c6a3ba183ece9592 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2) | 7.18e-09 | 198 | 130 | 9 | ed86b0247006befe55400c287d334d2202b470bd | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.18e-09 | 198 | 130 | 9 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | (3)_DC_Monocyte_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.18e-09 | 198 | 130 | 9 | e2b89f6d7c0007ccab62495cd543fe0e5513a9a4 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.18e-09 | 198 | 130 | 9 | 844f534551483c89ef789d1cfeb4680e54f794b2 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.18e-09 | 198 | 130 | 9 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.18e-09 | 198 | 130 | 9 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | 7.18e-09 | 198 | 130 | 9 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.18e-09 | 198 | 130 | 9 | f801157468e59b5d049f703feadc9bb0f11e85cc | |
| Computational | Neighborhood of HMMR | 2.37e-06 | 47 | 90 | 6 | GNF2_HMMR | |
| Computational | Neighborhood of CDC20 | 6.75e-06 | 56 | 90 | 6 | GNF2_CDC20 | |
| Computational | Neighborhood of CCNB2 | 7.50e-06 | 57 | 90 | 6 | GNF2_CCNB2 | |
| Computational | Neighborhood of RRM1 | 8.34e-06 | 88 | 90 | 7 | GNF2_RRM1 | |
| Computational | Neighborhood of TTK | 1.69e-05 | 39 | 90 | 5 | GNF2_TTK | |
| Computational | Neighborhood of PCNA | 2.10e-05 | 68 | 90 | 6 | GNF2_PCNA | |
| Computational | Neighborhood of CKS2 | 5.79e-05 | 50 | 90 | 5 | GNF2_CKS2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.79e-05 | 50 | 90 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Neighborhood of SMC2L1 | 1.56e-04 | 33 | 90 | 4 | GNF2_SMC2L1 | |
| Computational | Neighborhood of CDC2 | 1.63e-04 | 62 | 90 | 5 | GNF2_CDC2 | |
| Computational | Neighborhood of CENPF | 1.63e-04 | 62 | 90 | 5 | GNF2_CENPF | |
| Computational | Neighborhood of ESPL1 | 1.97e-04 | 35 | 90 | 4 | GNF2_ESPL1 | |
| Computational | Intermediate filaments and MT. | 2.53e-04 | 68 | 90 | 5 | MODULE_438 | |
| Computational | Neighborhood of CCNA2 | 2.53e-04 | 68 | 90 | 5 | GNF2_CCNA2 | |
| Computational | Neighborhood of RRM2 | 3.34e-04 | 40 | 90 | 4 | GNF2_RRM2 | |
| Computational | Neighborhood of RFC3 | 3.67e-04 | 41 | 90 | 4 | GNF2_RFC3 | |
| Computational | Neighborhood of CENPE | 3.67e-04 | 41 | 90 | 4 | GNF2_CENPE | |
| Computational | Cancer module 320: M phase. | 5.84e-04 | 20 | 90 | 3 | MODULE_320 | |
| Computational | Neighborhood of SMC4L1 | 6.75e-04 | 84 | 90 | 5 | GNF2_SMC4L1 | |
| Computational | Neighborhood of FEN1 | 1.21e-03 | 56 | 90 | 4 | GNF2_FEN1 | |
| Computational | Neighborhood of BUB1 | 1.28e-03 | 26 | 90 | 3 | GNF2_BUB1 | |
| Computational | Neighborhood of RFC4 | 1.57e-03 | 60 | 90 | 4 | GNF2_RFC4 | |
| Computational | Neighborhood of MKI67 | 1.60e-03 | 28 | 90 | 3 | GNF2_MKI67 | |
| Computational | Neighborhood of ERBB2IP | 2.11e-03 | 65 | 90 | 4 | GCM_ERBB2IP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.23e-06 | 187 | 129 | 9 | 4302_DN | |
| Drug | geldanamycin | ROCK2 EHBP1 ZNF704 TMOD3 MCM4 JMJD1C SETD2 ZFHX4 ZFR BOD1L1 AFF4 KNL1 | 1.39e-06 | 371 | 129 | 12 | ctd:C001277 |
| Drug | Demecolcine | NUSAP1 TICRR METTL3 BRIP1 TRIO DHRS11 MCM4 FAM13B JMJD1C TASOR2 CCDC88C FRY MDN1 BRCA2 SMARCA1 FH AFF4 ARAP2 | 2.35e-06 | 878 | 129 | 18 | ctd:D003703 |
| Drug | Thulium bromide | 3.51e-06 | 6 | 129 | 3 | CID000084454 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 6.88e-06 | 174 | 129 | 8 | 7530_DN | |
| Drug | resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 7.48e-06 | 176 | 129 | 8 | 958_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 8.47e-06 | 179 | 129 | 8 | 4585_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 9.95e-06 | 183 | 129 | 8 | 7498_DN | |
| Drug | Hycanthone [3105-97-3]; Down 200; 11.2uM; HL60; HG-U133A | 1.17e-05 | 187 | 129 | 8 | 1614_DN | |
| Drug | MultiHance | 1.46e-05 | 9 | 129 | 3 | CID000197281 | |
| Drug | 0316684-0000 [391209-55-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.47e-05 | 193 | 129 | 8 | 7052_DN | |
| Drug | Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; HL60; HG-U133A | 1.70e-05 | 197 | 129 | 8 | 1578_DN | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; PC3; HT_HG-U133A | 1.76e-05 | 198 | 129 | 8 | 5813_DN | |
| Drug | taxol | MAP1A LAMA2 LAMA5 LAMC1 PRPF40A PPIG TCERG1 PES1 ELF4 MAPK10 EIF2A TOP1 KIF11 | 1.83e-05 | 560 | 129 | 13 | CID000004666 |
| Drug | imazaquin | 2.07e-05 | 10 | 129 | 3 | CID000054739 | |
| Drug | Mustard Gas | NUSAP1 EHBP1 CASP8AP2 CENPE LAMA2 LAMA5 LAMC1 MCM4 ZNF235 RFX5 NCOR1 BRCA2 KMT5B PIK3C2G SMARCC1 NCOA1 TEKT1 MAPK10 EIF2A PLK4 KIF11 | 2.07e-05 | 1341 | 129 | 21 | ctd:D009151 |
| Drug | AC1L1G72 | 2.84e-05 | 11 | 129 | 3 | CID000003553 | |
| Drug | irinotecan | NUSAP1 CENPE ERC1 VPS4A RGS22 ARHGEF12 MCM4 ZBTB14 NCOR1 MDN1 NCOA1 BOD1L1 FH TOP1 | 4.65e-05 | 703 | 129 | 14 | ctd:C051890 |
| Drug | TMBr-3 | 4.88e-05 | 13 | 129 | 3 | CID000518955 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 5.52e-05 | 171 | 129 | 7 | 7535_DN | |
| Drug | Calcort | 6.25e-05 | 38 | 129 | 4 | CID000026709 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 9.36e-06 | 10 | 128 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 9.36e-06 | 10 | 128 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 9.36e-06 | 10 | 128 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 9.36e-06 | 10 | 128 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 9.36e-06 | 10 | 128 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 9.36e-06 | 10 | 128 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 9.36e-06 | 10 | 128 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 9.36e-06 | 10 | 128 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.70e-05 | 12 | 128 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.70e-05 | 12 | 128 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.21e-05 | 13 | 128 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.49e-05 | 15 | 128 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | breast carcinoma | ZNF704 ARHGEF28 SPTBN2 TRIM31 ARHGEF12 LAMC1 SMC2 JMJD1C TASOR2 CCDC88C BRCA2 KMT5B NCOA1 MAPK10 FILIP1L | 3.72e-05 | 1019 | 128 | 15 | EFO_0000305 |
| Disease | colorectal cancer (is_marker_for) | 6.55e-05 | 157 | 128 | 6 | DOID:9256 (is_marker_for) | |
| Disease | X-linked mental retardation with cerebellar hypoplasia and distinctive facial appearance (implicated_via_orthology) | 1.11e-04 | 4 | 128 | 2 | DOID:0080311 (implicated_via_orthology) | |
| Disease | laminin measurement | 1.11e-04 | 4 | 128 | 2 | EFO_0020528 | |
| Disease | testosterone measurement | ZNF704 TFEB MAP1A CENPE ARHGAP10 BCORL1 JMJD1C ZFHX4 NCOA1 MACF1 MYH16 MAPK10 UTRN JHY KNL1 BRWD1 | 1.32e-04 | 1275 | 128 | 16 | EFO_0004908 |
| Disease | free androgen index | 2.36e-04 | 374 | 128 | 8 | EFO_0007005 | |
| Disease | Malignant neoplasm of breast | EHBP1 BRIP1 RIBC2 BCORL1 LAMA2 NCOR1 SETD2 BRCA2 TAX1BP1 NCOA1 MACF1 BOD1L1 TOP1 DOP1A | 2.43e-04 | 1074 | 128 | 14 | C0006142 |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.62e-04 | 71 | 128 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | hydrocephalus (is_implicated_in) | 2.77e-04 | 6 | 128 | 2 | DOID:10908 (is_implicated_in) | |
| Disease | infertility (implicated_via_orthology) | 3.87e-04 | 7 | 128 | 2 | DOID:5223 (implicated_via_orthology) | |
| Disease | hypothyroidism (biomarker_via_orthology) | 4.14e-04 | 80 | 128 | 4 | DOID:1459 (biomarker_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 4.14e-04 | 80 | 128 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | QT interval | BRIP1 ARHGEF28 ARHGAP10 CWC27 LAMC1 FAM13B TBX20 RNF207 BRWD1 | 5.53e-04 | 534 | 128 | 9 | EFO_0004682 |
| Disease | colorectal carcinoma (is_marker_for) | 5.56e-04 | 37 | 128 | 3 | DOID:0080199 (is_marker_for) | |
| Disease | vesicoureteral reflux | 6.02e-04 | 38 | 128 | 3 | EFO_0007536 | |
| Disease | response to glucocorticoid, osteonecrosis | 6.50e-04 | 39 | 128 | 3 | EFO_0004259, GO_0051384 | |
| Disease | ciliopathy (implicated_via_orthology) | 7.01e-04 | 40 | 128 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 7.53e-04 | 41 | 128 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 7.53e-04 | 41 | 128 | 3 | C0858252 | |
| Disease | Adenoid Cystic Carcinoma | 9.60e-04 | 100 | 128 | 4 | C0010606 | |
| Disease | vital capacity | EHBP1 DSP CWC27 MYH7B ERC1 SPTBN2 LAMA2 JMJD1C NCOR1 R3HCC1L NCOA1 ELF4 UTRN FILIP1L | 9.70e-04 | 1236 | 128 | 14 | EFO_0004312 |
| Disease | non-melanoma skin carcinoma | 1.08e-03 | 265 | 128 | 6 | EFO_0009260 | |
| Disease | myopathy (implicated_via_orthology) | 1.20e-03 | 48 | 128 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 1.41e-03 | 13 | 128 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.43e-03 | 189 | 128 | 5 | EFO_0009932 | |
| Disease | Fanconi anemia | 1.64e-03 | 14 | 128 | 2 | cv:C0015625 | |
| Disease | Left ventricular noncompaction | 1.64e-03 | 14 | 128 | 2 | C1960469 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 1.64e-03 | 14 | 128 | 2 | C0677776 | |
| Disease | Autosomal recessive primary microcephaly | 1.89e-03 | 15 | 128 | 2 | cv:C3711387 | |
| Disease | puberty onset measurement | 2.18e-03 | 125 | 128 | 4 | EFO_0005677 | |
| Disease | electrocardiography | 2.24e-03 | 530 | 128 | 8 | EFO_0004327 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 2.43e-03 | 17 | 128 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | borna disease (biomarker_via_orthology) | 2.73e-03 | 18 | 128 | 2 | DOID:5154 (biomarker_via_orthology) | |
| Disease | Bone marrow hypocellularity | 2.73e-03 | 18 | 128 | 2 | C1855710 | |
| Disease | breast carcinoma (is_marker_for) | 2.99e-03 | 66 | 128 | 3 | DOID:3459 (is_marker_for) | |
| Disease | Left Ventricle Remodeling | 3.71e-03 | 21 | 128 | 2 | C0600520 | |
| Disease | Ventricular Remodeling | 3.71e-03 | 21 | 128 | 2 | C0600519 | |
| Disease | BREAST CANCER | 3.71e-03 | 21 | 128 | 2 | 114480 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 3.71e-03 | 21 | 128 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | hemorrhoid | 3.91e-03 | 147 | 128 | 4 | EFO_0009552 | |
| Disease | Seckel syndrome | 4.07e-03 | 22 | 128 | 2 | C0265202 | |
| Disease | Primary microcephaly | 4.07e-03 | 22 | 128 | 2 | C0431350 | |
| Disease | hypertrophic cardiomyopathy (is_implicated_in) | 4.07e-03 | 22 | 128 | 2 | DOID:11984 (is_implicated_in) | |
| Disease | resting heart rate | 4.10e-03 | 149 | 128 | 4 | EFO_0004351 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HDACRDAKEKRSKSQ | 1761 | P55196 | |
| THDRKSEDKLAKATR | 291 | Q92905 | |
| ILNSSTEEKFKAHDK | 711 | Q96RT1 | |
| VLATALHEKDKDKSR | 1216 | O15013 | |
| HSKEEKLRDIKSHQA | 561 | Q6ZU80 | |
| SHVLQFEDKSRKVKD | 421 | Q6UX04 | |
| DAEAHAFKSPSKENK | 281 | Q9NPI1 | |
| RALADDIDKTHKKFT | 61 | Q9BWW8 | |
| RADSHEEGSLEKKAK | 1196 | Q5H9F3 | |
| DHAQLSSKLRENKKT | 401 | Q5JWR5 | |
| EDRNSKATLDSDHKL | 1661 | Q8WZ64 | |
| HLKAKARAQESDSDR | 36 | Q9ULG3 | |
| KTDHRAKSDVSKDVH | 176 | Q9UKL3 | |
| RKHKNEDDNRASESK | 766 | Q9UHB7 | |
| EAKKLKHNADALSDR | 921 | Q9UHB7 | |
| DKKQKVERIASHDFD | 31 | Q9NZN5 | |
| DRKEHNCREEKKSST | 76 | Q7Z5L2 | |
| KHTNAEKKLADRESA | 111 | P42696 | |
| QLKKAHEAALEARAS | 716 | Q8IUD2 | |
| AKQDIEDTASDAKRK | 451 | P48382 | |
| KSASDHQRQEVLKKE | 846 | O75747 | |
| EATAAALRKKHADSV | 1186 | P12883 | |
| EKEQSHLKKRSSSLD | 466 | Q8N1W1 | |
| LSAKKKDSHLQEADI | 151 | A1A4S6 | |
| AEAHAKVRLSNKVEA | 741 | P33991 | |
| SAEKEKQRSEAKHIL | 4106 | Q9NU22 | |
| RKFHISKTQDKSLEE | 776 | Q9P2G4 | |
| DKALDQKVRSVEHKA | 1496 | P78559 | |
| KKEDLHRISKDSLES | 31 | Q6NUN7 | |
| DSEHNKLKASQARDL | 321 | P53779 | |
| HSLEEKASREESAKK | 156 | Q99607 | |
| KLDRKKAVDQHNAEA | 516 | P52732 | |
| DITEKSDGRKAAHEK | 861 | P52732 | |
| SKISIKLSKDHDNDN | 741 | Q4FZB7 | |
| HSIANAKFLETAKKD | 546 | Q15652 | |
| TKDHLVEEKASLQKS | 701 | Q9NYF5 | |
| EKHREAEKSHSRGKD | 106 | Q8WVS4 | |
| RHQSNVDRKEKSAKD | 271 | Q8WVS4 | |
| KSKLHDLELDRDTDK | 391 | Q9P219 | |
| QKLEEALKEHKSSVS | 451 | Q8N1V2 | |
| RELKQVFKAADSKHT | 561 | Q5JST6 | |
| RQLEEESKAKSALAH | 1366 | A7E2Y1 | |
| SRNAEEKAKKAITDA | 1751 | P13535 | |
| KKLDASSEKQSADHQ | 146 | O75564 | |
| EQAREAKSHQKCSKS | 226 | Q86W56 | |
| AKDSRDEENKKSHNG | 1641 | Q8NG31 | |
| VAKEAKDLAHEATKL | 1941 | P24043 | |
| SKKIAHAKAVAAEAQ | 2626 | O15230 | |
| KDKHAEDNEKRLAAL | 751 | Q76FK4 | |
| AATKDNEHKRSLTKT | 286 | Q9BXS6 | |
| HQHLKEKAEARKESA | 91 | Q9UJV9 | |
| ENLDDSVFSKRHAKL | 496 | Q68DK7 | |
| QKIKEATEKARHETF | 56 | Q9H4K1 | |
| DRKDLHHQGSKSDDK | 3211 | Q9UPN3 | |
| KKSRKHAASDVDLEI | 211 | Q86U44 | |
| KSNEHDHSKSKEKDR | 526 | Q13427 | |
| DDDSHSKKKRQRSES | 836 | O75400 | |
| SALESLAEFSKKHQK | 876 | Q9BX63 | |
| LSSDDKTERKSKHRN | 781 | Q8NFC6 | |
| KDSASLEVVKKDHVA | 221 | Q8NA61 | |
| KEINAAHAILSDSKK | 76 | Q8N7S2 | |
| HDESLKKNDRFIASV | 236 | P51587 | |
| SKTRKKIFHEANADE | 326 | P51587 | |
| DEKASVVSREKSHKA | 286 | Q14241 | |
| KSQDDVHTAARVLKD | 291 | Q9P218 | |
| NAKETHTKLALAEAR | 266 | Q4L180 | |
| LQKLHDALDAKSKEF | 211 | P07954 | |
| QDDISAAKDRHKKNL | 166 | Q12934 | |
| KNLHSEISGKRDKSE | 931 | P15924 | |
| ASAVARKKLLHNSED | 1666 | Q9NSI6 | |
| KKKHASLRQTESDPD | 776 | Q8NDI1 | |
| EAKNKAHEAERIASA | 1421 | P11047 | |
| QDDKSSDKQLRIKHV | 1921 | Q8WYP5 | |
| RELSDLKKHLKEASA | 2866 | Q5TBA9 | |
| HEAKKAAKQEARSDK | 491 | Q9BY44 | |
| LDDAHKKANSQEKTS | 1056 | A2RUR9 | |
| AFKLHDKDPEKAAAT | 206 | Q6UWP2 | |
| HRKAKDSALQSIESK | 1556 | Q02224 | |
| NDLKAKSASIRAHLE | 2541 | P46939 | |
| KSASIRAHLEASAEK | 2546 | P46939 | |
| EKDKAFKEQLSHLAT | 271 | Q6ZRF8 | |
| ELEKKLSEAKSRHDS | 271 | Q9BZY9 | |
| KKRFSDATSKAHQLE | 221 | Q86VP1 | |
| ESRALAKERQKKDNH | 226 | P19484 | |
| KADNDNRDHKEKLER | 546 | Q96KN7 | |
| DEAHRIKNEKSKLSE | 311 | P28370 | |
| SKDHLKDIHRSLKDA | 156 | Q9ULS5 | |
| TSKHAAADEALKILQ | 396 | O15226 | |
| DQAKADSHRAKKDIK | 831 | P35251 | |
| LSAKKKESHLQEADT | 151 | A6NI28 | |
| QALHKETFSKKAEDT | 806 | Q8NE09 | |
| DASKKKESKDHQLLR | 736 | Q15788 | |
| VSKTKESKHEAARLE | 1836 | O75376 | |
| QTCREEHKKKHSDAS | 21 | B2RPK0 | |
| TKDARDKLADHLAKV | 271 | Q969V4 | |
| RKDSKAHEQALAELT | 776 | Q15477 | |
| DTKVKKNSDASDNAH | 521 | O00444 | |
| QEADAVTHSDKSLKR | 111 | A0A1B0GV85 | |
| SAATKAKHLAAVEER | 876 | Q92922 | |
| AKRDSLQVSKATHKA | 341 | Q86WD7 | |
| ELSSSHHNREKAKEK | 321 | Q86X95 | |
| LNDAESRKRAEHKTE | 16 | Q4G0F5 | |
| KAFAKASDLKRHENN | 396 | O43829 | |
| DSHVEKKARRSEQKD | 1171 | Q9H9J4 | |
| AAVNSKDTHLDAKEL | 1611 | Q86UP3 | |
| PKRDAKENTEEASHK | 556 | O95625 | |
| REESTIAHQEDSKKK | 546 | Q7Z2Z1 | |
| EANKLAEKRKAHDEA | 561 | O00541 | |
| AHDEAVRSEKKAKKA | 571 | O00541 | |
| EKADSIERRHKKNQD | 1251 | O15020 | |
| KAKDELSAQAEVKKH | 1616 | O15020 | |
| AAKHAKDSRFKAIEK | 751 | O14776 | |
| KRALEKNESSFASHK | 151 | Q96DB5 | |
| IDAKSKKSNIRIHED | 166 | Q7Z4S6 | |
| KASSLIEEAKKAAGH | 1161 | Q9Y490 | |
| KTLRENSELATEHKK | 126 | Q8NHR7 | |
| QRKADHEADKKRNLE | 516 | O75116 | |
| AEHKATKARLADKNK | 706 | O75116 | |
| SAEDEKRKRKCQKHA | 126 | O43159 | |
| HESRKDSAKRAVQDD | 1321 | Q68DE3 | |
| NISKHKREAEDGAAK | 916 | O95347 | |
| QASEHTKSKHESRKE | 181 | Q9BZ95 | |
| KRKKSNKHDSSRSEE | 196 | Q9BZ95 | |
| NKHDSSRSEERKSHK | 201 | Q9BZ95 | |
| HDSIKELDSLSKVKN | 646 | Q9BYW2 | |
| TTLAKTEKEKQALDH | 151 | Q9H6N6 | |
| HVRKLEDSLSEANAK | 411 | Q9H6N6 | |
| DTKKASRILDHEKEN | 36 | Q6ZNC4 | |
| KLVSDSLSEHEKNKN | 756 | Q96KR1 | |
| NSELKHRSSKKDLLE | 541 | Q6NXT6 | |
| LKEDERVDSTAHKKN | 2326 | Q5VWN6 | |
| KKDHTASLLNLKSEE | 236 | Q9UMR3 | |
| KLQDKSETHDKVAAL | 201 | Q504Y3 | |
| KRDKVHSNSDCGKDT | 231 | Q14590 | |
| EKDREKSKHSNSEHK | 41 | P11387 | |
| VKRQSKSEHETSDAK | 551 | P40818 | |
| REFAKALETNTHVKK | 216 | Q9NZR1 | |
| RETSDRAHDENKKKA | 946 | Q5T200 | |
| RDAAHELNEEKRKSA | 1276 | O75962 | |
| LKDFAKALETNTHVK | 216 | Q9NYL9 | |
| EECDKAFKRHSSLAK | 356 | A0A1W2PQL4 | |
| AEAARVSKNAHKESR | 16 | Q5SQQ9 | |
| EAHSDKAKESIRAKC | 46 | Q9UN37 |